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          Supramolecular chemistry has been a very important research area in the past 
several decades.  In this research field, molecular containers, such as cyclodextrin, 
attracts special attention due to their wide applications both in academia and industry.  
Cucurbit[n]uril (CB[n]), as a new generation molecular container, has selective and tight 
binding towards lots of cations and neutral molecules.  A homologous family of CB[n] 
has been discovered including CB[5]-CB[8], CB[10], iCB[n], ns-CB[10] and ns-CB[6].  
CB[n] analogues and derivatives have also been developed.  CB[n] still has several issues, 
such as low solubility in water, difficulty to be functionalized, and slow association and 
dissociation kinetics.  This thesis describes efforts to address these issues by developing 
new CB[n] type molecular containers and carrying out mechanistic investigations.  Three 
chapters are included in this thesis. 
           Chapter 1 is a literature review of molecular encapsulation and molecular 




and present examples of molecular container, such as cyclodextrin.  This is followed by 
an introduction to CB[n] molecular containers and their supramolecular chemistry. 
          Chapter 2 introduces new acyclic CB[n] congeners II-5a and II-5b.  II-5a and II-
5b are obtained from step-wise synthesis with reasonable yields.  This step-wise synthetic 
route avoids difficult separation process.  We measured the binding constants of II-5a 
towards a number of guests and found the binding affinity is usually comparable to CB[7].  
The recognition property of II-5a is investigated in depth.  We found that the length and 
functional groups of the guests greatly influence the binding affinity.  Nevertheless, the 
charge and size of the guests do not have as a big influence on the binding constants as 
CB[7].  We discovered that the ionic strength of the buffer is critical for the binding 
constant.  By comparing the recognition property of II-5a and II-6, it is discovered that 
the substituted o-xylyene walls are important for the tight binding compounds.  II-5a and 
II-5b are new examples of CB[n] type molecular containers.  They retain most of the 
good recognition property of CB[n] and have advantages compared to CB[n], including 1) 
aromatic walls that makes further functionalization possible; 2) acyclic structure that 
enables fast association and dissociation kinetics. 
          Chapter 3 describes the mechanistic study of CB[n] forming reactions.  Another 
possible way to synthesize CB[n] molecular container is to use aldehydes instead of 
paraformaldehyde.  But neither previous researchers nor our work has succeeded to make 
the aldehydes participating CB[n] forming reactions happen.  Mechanistic investigation 
was carried out to explain why this reaction simply does not occur.  We used III-7 
instead of glycoluril to avoid cyclization reactions.  Several reasons are discovered: 1) 




yielded, such as III-15S, III-16S, III-17S and III-18S, which are not able to continue the 
reaction to form macrocycles; 3) a small equilibrium constant for the chain grouth 
reaction.  This study explains why aldehydes usually do not participate in CB[n] forming 
reactions.  This work could also lead to the discovery of certain aldehydes that can form 
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І. Chapter 1: Literature Review of Molecular Encapsulation 
 
1.1 Introduction. 
          Cram, Lehn, and Pedersen have defined the area of supramolecular chemistry as a 
contemporary discipline with their pioneering work.  Supramolecular chemistry is the 
discipline of chemistry which involves intermolecular interactions where non-covalent 
rather than covalent bonds are established between the interacting species, a majority of 
which are of the host-guest type.  A variety of supramolecular host molecules, or 
molecular containers in another word, have been developed and well studied including 
crown ethers, cyclodextrin (CD), calixarene, and cucurbituril (CB[n]).  Molecular 
containers often show selective recognition towards cation, anion and neutral guest 
molecules.  Based on the molecular encapsulation principle, a lot of applications have 
been developed for molecular containers. CD has been one of the most widely used 
molecular containers. Its applications include drug delivery, chiral separation, and 
odor/scent control.  CB[n], the new generation of molecular container, is well recognized 
for its tight and selective binding towards cations and neutral guests.  The high affinity 
binding is critical for numerous biological applications.  Its rigid structure of CB[n] and 
the formation of thermodynamically stable host-guest complexes have enabled its 
applications for molecular machine, reaction catalysis, drug delivery, and so on.  
Nevertheless, some weaknesses of CB[n] include poor solubility in water and slow 
kinetics of association and dissociation, which have stopped CB[n] from wider 





Accordingly, scientists have been developing alternate routes to get water soluble CB[n] 
analogues or derivatives.      
1.2 Molecular Encapsulation. 
     Molecular encapsulation in supramolecular chemistry refers to the confinement of a 
guest molecule inside the cavity of a supramolecular host molecule.  It is often referred to 
as host-guest chemistry.  Its application has ranged from academic research to industrial 
production.  
 
1.2.1 Early Examples of Molecular Encapsulation. 
     In 1967, Charles Pedersen synthesized crown ether.1 In his report, he described the 
simple synthesis of 33 cyclic polyethers derived from aromatic vicinal diols and 
containing from 9 to 60 atoms including 3 to 20 oxygen atoms in the ring (some 
examples are given in Figure I-1, compound I-1-I-5).  Many of these crown ethers 
containing five to ten oxygen atoms form stable complexes with some or all the cations 
of: Li+, Na+, NH4+, RNH3+, K+, Rb+, Cs+, Ag+, Au+, Ca2+, Sr2+, Ba2+, Cd2+, Hg+, Hg2+, 
La3+, Tl+, Ce3+, and Pb2+.  Many of these complexes were isolated in the crystalline form 
depending on the anion.  They appear to be salt-polyether complexes formed by ion-
dipole interaction between the cation and the electrostatically negatively charged oxygen 
atoms of the polyether ring.  Since the discovery of crown ether, other molecular 
containers have also been synthesized and well studied, e.g. cyclodextrin, calixarene, and 








Figure I-1. Examples of crown ethers.      
 
1.2.2 Cyclodextrin Molecular Container. 
        Cyclodextrin was first discovered in 1891 by Villiers.2  Its structure was elucidated 
in 1948-1950.3  French and Cramer intensively worked on the enzymic production of 
cyclodextrins and characterizing their true chemical and physical properties in the 
1950s.4,5  Cyclodextrins comprise a family of three well-known industrially produced 
major, as well as several rare, minor cyclic oligosaccharides.  These three major 
cyclodextrins are crystalline, homogeneous, non-hygroscopic substances, which are 
torus-like macro-rings built up from glucopyranose units.  The α-cyclodextrin comprises 
six glucopyranose units, β-CD comprises seven such units, and γ-CD comprises eight 
such units (Figure I-2).  The shape of cyclodextrin is also displayed in Figure I-2.  It has a 
hydrophobic cavity and hydrophilic portals and outer walls.  
          The slightly apolar CD cavity is occupied by water molecules in an aqueous 
solution.  Guest molecules which are less polar than water can readily substitute these 
water molecules.  Different host:guest ratios can been formed.  But the most frequent one 





          Based upon molecular encapsulation, cyclodextrin has lots of applications. One of 
the most important applications is drug delivery.  The primary purpose of drug delivery is 
to deliver drugs to the targeted site for a necessary amount and necessary period of time 
efficiently and precisely.  Investigation proved that natural cyclodextrins do not exhibit 
toxicity.6  Cyclodextrin and its derivatives usually are soluble in water.  As a type of 
easily functionalized and bioadaptable molecular container, cyclodextrin is suitable for 
drug delivery applications.    
 
 









































































































          Numerous drug delivery applications with cyclodextrin are reported, including 
drug solubility enhancement,7 drug stabilization,8 drug absorption enhancement, 
alleviation of local and systemic toxicity of certain drugs, and cyclodextrin based drug 
delivery systems.   
          There are a good number of drugs prescribed in the market with a poor solubility in 
water.  In order to formulate the drugs for injection, their solubility in water needs to be 
enhanced.  Cyclodextrin and its derivatives are capable to solubilize drugs based on host-
guest inclusion.  The solubilization ability of cyclodextrin is quantitatively evaluated by 
the phase solubility method developed by Higuchi and Connors.9  The phase solubility 
diagrams are classified as either type A or type B (Figure I-3).  As for type A, a very 
soluble complex is formed and a complex of moderate solubility for type B.  They can be 
further classified into subtypes AL, AP, AN, BS and BI.  To reach the maximum solubility 
enhancement, cyclodextrins were functionalized by introducing hydroxylalkyl groups or 
sulfonate groups to the backbone or forming branched cyclodextrins.  The solubilizing 
effect of 2-hydroxyethyl-β-CD (I-6) and 2-hydroxypropyl-β-CD (I-7) with different 
degrees of substitution on poorly water-soluble drugs, such as hydrocortisone (I-8), 
digitoxin (I-9), diazepam (I-10), and indomethacin (I-11) was studied by Müller and 
Brauns.7  Compared to their parent β-CD, which has a limited solubility and thus poor 
solubility enhancement capability, these two hydroxyalkylated β-CDs demonstrated the 
AL-type diagram pattern with the guest solubility increasing linearly up to 10% (w/v) 
concentration of the hosts.  By comparing the solubility enhancement capabilities of 
different degrees of substitution, researchers discovered that the degree of substitution 





functionalized CD for drug solubilization.  But the sulfated cyclodextrin has a 
significantly weaker binding, because negative charges are surrounding the rims.10  To 
avoid this problem, sulfoalkylated cyclodextrins were developed and studied.  The study 
on the inclusion ability of sulfopropyl-β-CD (I-12) and sulfobutyl-β-CD (I-13) with 
different degrees of substitution towards testosterone (I-14) and progesterone (I-15) 
demonstrates sulfoalkylated cyclodextrins’ tighter binding than β-CD.11  Sulfobutyl-β-CD 
is reported to be a good solubilizer for various poorly water soluble drugs such as 
pilocarpine (I-16), cinnarizine (I-17), indomethcin, naproxen (I-18), warfarin (I-19), 
papaverin (I-20), thiabendazole (I-21), and miconazole (I-22).12  
 
Figure I-3. Phase diagram showing different solubility behaviors. 































Figure I-4. Compounds for drug solubility enhancement. 
 
          Cyclodextrin’s application to stabilize drugs is based upon the principle that CD is 
capable to accelerate or decelerate reactions occurring to the molecules encapsulated 
inside it.  Cyclodextrins are used to stabilize digoxin (I-23),8 one of the potent cardiac 
glycosides.  Digoxin is susceptible to hydrolysis in acidic media. (Figure I-5)  This 
































































R = (CH2)3OH or H I-7
R' = (CH2)3SO3H or H    I-12






















































































digoxin.  Research showed that the addition of cyclodextrins decelerates the acid-
catalyzed hydrolysis of the glycoside bonds.  In the absence of cyclodextrins, the 
hydrolysis rate constant is 0.17 h-1.  In the presence of α-CD, β-CD and γ-CD, the rate 
constants are 0.108, 0.002 and 0.025 h-1, respectively.     
  
Figure I-5. Acid-catalyzed hydrolysis of the glycoside bonds in digoxin. 
 
          Cyclodextrin has a lot of applications even though it usually has a weak binding 
towards guests.  CB[n] family, as a type of hosts with tight and selective binding towards 
lots of guests, is a good candidate for similar or novel applications.  We will discuss this 
type of novel host molecules in the next chapter. 
 
1.3 Cucurbituril (CB[n]) Molecular Container. 
         CB[n] is cyclic glycoluril oligomers with methylene bridges and a shape resembles 
a pumpkin.  Since the discovery of CB[6] in 1981 by Mock and co-workers,13 the CB[n] 
family has grown to homologues, including CB[5]-CB[8], CB[10] and nor-seco-CB[n], 























Their unique shapes, tight and selective bindings enable CB[n] to play a very important 
role in molecular recognition.   
 
1.3.1 Introduction to Cucurbituril. 
          Behrend reported an insoluble polymeric material from the condensation of 
glycoluril and formaldehyde in concentrated HCl in the year of 1905.14  And then 75 
years later, in 1981, it was clarified that the polymeric material discovered by Behrend is 
actually cucurbit[6]uril, a macrocycle composed of six glycoluril (I-24) units and twelve 
methylene bridges.13  At that time, CB[6] was the only cucurbituril detected by Mock. 
Later other CB[n] family members with different sizes including CB[5], CB[7] and CB[8] 
were discovered (Figure I-6).15,16  Also, inverted CB[n] with the protons on one of the 
glycoluril units pointing into the cavity was discovered.17  Recently, the largest CB[n] 
that has ever been discovered, CB[10],18 was separated from CB[10]•CB[5].19  The vast 
cavity of CB[10] (870 Å3) enables it to host some big molecules, such as porphyrin.  A 
mixture of these homologues is obtained from the condensation reaction of glycoluril and 








Figure I-6. Synthesis and structure of CB[n]. 
 
          All the above CB[n]s are only varied in size. The recent outcome in the searching 
for new CB[n] has been the synthesis of CB[n] with different shapes. Basically obtained 
from a kinetically controlled reaction, bis-ns-CB[10] is a brand new type of CB[n], with 
two cavities, inside which two guests could be accommodated and influence each other.20 
As for bis-ns-CB[10], the size of cavities is comparable to that of CB[6] or CB[7]. Bis-
ns-CB[10] has most of the binding profile same as CB[n]. It also could bind to larger 
guests considering the five glycoluril units composing each of the two cavities. Bis-ns-
CB[10] displays a homotropic allostery based on a guest size induced preorganization 
mechanism. It could either expand or contract the cavity according to the size of the guest 





































































































































Figure I-7. Bis-ns-CB[10] and its size change responding to guest size. 
 
          Another novel CB[n] discovered recently is (±)-bis-ns-CB[6] (Figure I-8) which 
lacks one methylene bridge compared to CB[6].21  It is synthesized by conducting the 
condensation reaction between glycoluril (1 eq) and paraformaldehyde (less than 2 eq.).  
As a racemic mixture of two enantiomers, researchers are able to use (±)-bis-ns-CB[6] to 
do enantio- and diastereoselective recognition inside its cavity.  This chiral bis-ns-CB[6] 
undergoes moderately diastereoselective complexation  with chiral amines including 
amino acids, amino alcohols and meso-diamine.  It promises to greatly widen the scope 
of CB[n]’s application since it is able to create enantioselective molecular devices.  From 
a similar reaction as chiral bis-ns-CB[6], an achiral ns-CB[6] (I-26, Figure I-8) was 
synthesized.22  It lacks one methylene bridge compared to CB[6].  Treating it with o-



















































































diastereoselective recognition towards unsymmetrical guests.  The back-folding of long 
chain alkanediammonium ions is also promoted by this new CB[n] derivative in water. 
 
Figure I-8. Structures of (±)-bis-ns-CB[6] and ns-CB[6]. 
 
1.3.2 Cucurbituril Derivatives, Analogues and Acyclic Congeners. 
          Besides the CB[n] family, CB[n] analogues and derivatives also attract researchers’ 
interest.  CB[n] analogues and derivatives are prepared in order to alleviate the weakness 
of regular CB[n], including limited solubility in water and an inability to modify internal 
or external molecular surface of the CB[n] molecule.  Researchers hope that by altering 
the shape and size of the cavity or providing different functional groups that directly 
interact with guests, the range of the potential CB[n] applications could be dramatically 
expanded.  There have been numerous attempts to prepare CB[n] derivatives by using 
substituted glycoluril derivatives in CB[n] forming reactions.  In 1992, Stoddart and co-
workers reported the first characterized CB[n] derivative with the synthesis of Me10CB[5] 
from dimethylglycoluril and formaldehyde under acidic conditions.23  Since then, various 



















































































































preferentially the smaller CB[n] derivatives are formed, usually CB[5] and CB[6] 
derivatives.   
          Another pathway to obtain CB[n] derivatives is by the direct functionalization of 
CB[5]-CB[8].  In 2003, Kim and co-workers reported the direct oxidation of CB[5]-CB[8] 
with K2S2O8 in water to yield the perhydroxylated species (HO)2nCB[n] (Figure I-9).24  
The good solubility of (HO)12CB[6] in DMSO and DMF allows its subsequent 
derivatization.  (HO)2nCB[n] can be alkylated by treatment with allyl bromide to yield 
(CH2=CHCH2O)12CB[6].  The allylated compound (CH2=CHCH2O)12CB[6] is then 
treated with I-28 in photochemical reaction to afford (CH3(CH2)4S(CH2)3O)12CB[6].  
They demonstrate an approach to covalently anchor (CH2=CHCH2O)12CB[6] onto a 
patterned glass surface through the photochemical reaction.  This CB[6] modified surface 







Figure I-9. Synthesis and functionalization of (HO)2nCB[n]. 
 
          Later, Kim and coworkers synthesized a modified amphiphilic CB[6] from the 
(CH2CHCH2O)12CB[6] (Figure I-10a).25 This amphiphilic CB[6] (I-29) is able to form 
vesicle.  They found the modified CB[6] surface can form stable host-guest complex with 
FITC (fluorescein isothiocyanate) - spermine conjugate ligand.  This structure was 
observed under a confocal microscope, which confirmed the accessibility of the host 
molecule in the vesicle membrane toward the spermine-based guest.  This research 
provides a new noncovalent, modular approach to the modification of vesicle surfaces 
with CB[6] derivatives.  The researchers then synthesized sugar-decorated vesicle from 
the amphiphilic CB[6] and thiourea linked α-mannose-spermidine conjugate.  When they 
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mannose, the aggregation occurred immediately.  In contrast, no aggregation was 
observed when they mixed free ligand or vesicle decorated with a galactose-spermidine 
conjugate with ConA.  This result illustrates the specific and multivalent interactions 
between the mannose-decorated vesicle and ConA.  
          In another application of functionalized CB[7], researchers succeeded to anchor 
modified CB[7] (I-30, Figure I-10b) on a gold solid surface.26  Proteins were 
immobilized on this solid surface through noncovalent interaction of CB[7]-
ferrocenemethylammonium (I-31) pair.  They used glucose oxidase (GOx) as a model 
protein to detect glucose.  This process was monitored by surface plasmon resonance 
(SPR) technique.  They then utilized this modified gold surface as a glucose sensor and 
investigated it by cyclic voltammetry and glucose-concentration-dependent current 
measurements (Figure I-10c).  It turned out to be no appreciable current in the absence of 
glucose and an increasing catalytic current with increasing glucose concentration, which 






Figure I-10. Functionalized CB[n] and its application as bio-sensor. 
 
          Kim and co-workers even used the modified CB[6] (C8H17S(CH2)3O)12CB[6], I-
32)27 to form ion channel (Figure I-11).  In order to study the proton transport across 
membranes, large unilamellar vesicles were prepared from egg yolk L-α-phosphatidyl-
choline (EYRC), cholesterol, and dicetyl phosphate with C8H17S(CH2)3O)12CB[6].  A 
pH-sensitive dye 8-hydroxypyrene-1,3,6-trisulfonate (HPTS) was entrapped inside the 
vesicles to monitor the proton flux through the membranes.  They were able to measure 
the proton flux by watching the fluorescence intensity of HPTS.  They found that this 
novel artificial ion channel can transport proton and alkali metal ions across a lipid 














































amount of neurotransmitter acetylcholine, which forms a stable host-guest complex with 
CB[6] derivatives in water.  
 
Figure I-11. Modified CB[n] as ion channel. 
 
          Although these results show very promising applications, the same significant issue 
was not solved in this direct functionalization, that is, only the smaller modified CB[n]s, 
CB[5] and CB[6], can be obtained with a good yield.  It is still very hard to synthesize 
derivatives of the larger CB[n]s, which have larger cavities and more applications. 
          Cucurbituril analogues have also been synthesized.  One of these new compounds 
was synthesized by Isaacs and co-workers.28  They synthesized CB[6] analogues (I-35) in 
high yield from the cyclization reactions of bis(phthalhydrazide) (I-33) and glycoluril 
ether building blocks (I-34). These CB[n] analogues have noteworthy features including 
electrochemically, UV/Vis, and fluorescently active “walls”, elongated shapes, and 
decent solubility in both organic and aqueous media.  Another CB[n] analogue was 
prepared by Miyahara from the acid-catalyzed condensation reaction of ethyleneurea (I-
36).29  The product, hemicucurbituril (I-37), was obtained with a very high yield. It does 

























such as HCONH2 and HOCH2CCH.  Similar to CB[n] derivatives, these CB[n] analogues’ 
applications are limited by their relatively small cavities.  
          In order to further expand the scope of CB[n] family, researchers have been 
working on acyclic CB[n] congeners as well.  Isaacs synthesized a novel acyclic CB[n] 
congener (I-38) with alternating glycoluril (I-39) and aromatic rings (I-40), and 
preorganized into the  a,a,a,a-conformation required for molecular recognition.30  It 
displays selective binding towards positively charged guests and competitive binding 
with alkali metals present in solution.  But the binding affinity is weak compared to 
cyclic CB[n] (only 104 towards hexanediamine, compared to 106 for CB[6]), which might 
be due to shortage of enough glycoluril units.  Recently, Sindelar prepared a glycoluril 
trimer (I-44) from the condensation reaction of glycoluril diether (I-41) with glycoluril 
bisether (I-42) or tetrakis hydroxyl methyl glycoluril (I-43).31  This glycoluril trimer is 
able to encapsulate bispyridinium ethylene (I-45, Ka = 8.4 × 104 M-1) and methylviologen 
(I-46, Ka = 7.5 × 104 M-1) guests in the solid state and aqueous solution.  This acyclic 
congener CB[n] with more glycoluril units still has only a weak or moderate binding 
towards positively charged guests.  We hypothesize that the binding will be much 
stronger if we add more glycoluril units into the congener.  The reason is more glycolurils 
will help form a preorgnized carbonyl portal, which is necessary to form a tight binding 
by ion-dipole interactions.  From previous study, it shows that at least four glycoluril 






Figure I-12. Examples of CB[n] analogues and congeners. 
 


















































































































































R3 = CH2 or C6H4













          As a novel host with a tight and selective binding towards various guests, 
cucurbituril has lots of applications, such as molecular machines, catalysis and drug 
delivery. 
 
1.3.3.1 Molecular Machines. 
          Examples of CB[n] molecular machines include molecular switches under  
chemical, photochemical and electrochemical controls.   
          An early example was a chemical controlled molecular switch based on CB[6] 
developed by Mock.32  In his study, he developed a pseudo-rotaxane system of CB[6] and 
triamine (I-47, Figure I-13).  CB[6] is able to shuttle along the guest, triamine, by 
changing the pH value.  
 
Figure I-13. Chemcially controlled molecular machine. 
 
          An example for electrochemically controlled molecular switch is the complex of 
CB[7] and methylviologen (MV, I-46), which was developed by Kim and co-workers.33  
CB[7] forms a stable 1:1 complex with MV2+ (Ka = 2 × 105 M-1) and its reduced forms 
MV+• (Ka = 8.5 × 104 M-1) and MV0 (Ka = 2.5 × 102 M-1).  A series of electrochemical 













suppressed effectively by forming a stable complex with CB[7]; 2) direct electron 
transfer to and from the MV2+-CB[7] complex is observed, which is rare in host-guest 
complexes. 
          Based upon the knowledge above, Kim utilized CB[8]’s larger cavity to 
accommodate two flat aromatic ring systems.34  A novel [2]pseudorotaxane molecular 
machine based on the complex of CB[8] and dimeric viologen (I-47, Figure I-14) was 
synthesized.  Dimeric viologen forms 1:1 host-guest complex with CB[8]. Similar to 
methyl viologen, it can go through electrochemical and photochemical process.   By 
giving this complex an electrochemical or photochemical stimulus, the dimeric viologen 
can reversibly convert between dication and tetracation.  The change of the electron 
density and charge leads to the folding and unfolding of the thread reversibly, which 
makes it a reversible molecular machine.  
 
Figure I-14. Photochemically controlled molecular machine. 
 
1.3.3.2 Catalysis. 
          Catalysis is very important in chemistry, since it increases the reaction rate.  The 
mechanism of the catalysis could be very different depending on different reactions.  As 
CB[8]








for CB[n], it usually is that CB[n] encapsulate starting material molecules and thus bring 
them closer to each other. 
           Shortly after CB[6] was discovered and characterized, its application to catalyze 
chemical reactions was developed.  Mock discovered that the dipolar cycloaddition 
between azide (I-48) and alkyne (I-49) was catalyzed by CB[6].35  CB[6] accelerates this 
reaction by 5.5 × 104 fold and the reaction is highly regioselective, which makes this 
reaction a very elegant click reaction.    
 
Figure I-15. Dipolar cycloaddition reaction catalyzed by CB[6]. 
 
           Kim and co-workers developed a photoreaction based upon CB[8] (Figure I-16).36  
Two molecules of (E)-diaminostilbene dihydrochloride (I-50) would have [2+2] 
photoreaction.  This photoreaction has a small reaction rate in the solution due to the 
large distance between reactant molecules.  CB[8] could act as a catalyst for this reaction 
as a result of the formation of 1:2 host-guest complex.  Inside the CB[8] cavity, (E)-
diaminostilbene dihydrochloride molecules are brought to a very close distance, which 
leads to a much higher reaction rate (150 times higher).  Also this CB[8] catalyzed 
photoreaction is stereoselective.  The [2+2] photoreaction product has a high 
stereoselectivity (syn-anti ratio > 95:5) in the presence of CB[8]. 












Figure I-16. [2+2] photoaddition reaction mediated by CB[8]. 
 
1.3.3.3 Drug Delivery 
          Drug delivery is a very important research topic in chemistry, biology and 
pharmacology.  In order to improve the efficacy and safety of certain drugs, researchers 
use drug delivery technologies to modify drug release profile, absorption, distribution and 
elimination.  As mentioned above, the cyclodextrin family has been widely used for drug 
delivery purposes.  CB[n] family, especially CB[7], as a kind of macrocycles with high 
affinity and high selectivity towards various clinical drugs and reasonable solubility in 
water, is a very promising candidate for drug delivery.  Recently, a number of reports 
have been made on CB[n]’s application for drug delivery purpose. 
          One example is reported by Nau and co-workers.37  In their study, benzimidazoles 
were selected as drugs, including lansoprazole (I-52) and omeprazole (I-53), very 
important drugs that are prescribed worldwide to cure diseases related to the secretion of 
gastric acid, or in another word, proton-pump inhibitors.  In order to study the 
complexation-induced pKa shifts easily, chromophoric guest, thiabendazole (TBZ, I-54), 
was used in the research.  Researchers found that the pKa of TBZ was increased by as 





















far reported for an organic macrocyclic host.  Proton-pump inhibitors have to convert to 
their active form, sulfonamide form (I-55), before they can react with cysteine residues of 
gastric (H+-K+)-ATPase and reduces the production of gastric acid (Figure I-17).  But this 
activation process is usually slow. Also the sulfonamide form is unstable.  It would go 
through dimerization and decomposition processes.  By forming a 1:1 inclusion complex, 
CB[7] catalyzes the rapid and highly efficient formation of the active form of the drugs 
(sulfonamide form).  Meanwhile, CB[7] stabilizes this sulfonamide form and thus the 
decomposition pathways are effectively suppressed.  So CB[7] serves as a very useful 
agent to stabilize and activate proton-pump inhibitors. 
 
Figure I-17. Decomposition and reaction pathways of proton-pump inhibitor drugs. 
 
          Kim and his co-workers reported drug delivery research on functionalized CB[n], 
galactosylated CB[n] (Figure I-18).38  The galactosylated CB[n] (I-57) used in their study 
is derived from CB[6] with 12 thioglucose groups on it.  It can form a host-guest complex 
with dextran-spermine conjugate (I-58).  The molar ratio of dextran-spermine conjugate 
and CB[n] residue can vary, such as 100:12 (Dex-spm-gCB-12) and 100:25 (Dex-spm-
gCB-25).  The complex of CB[n] and dextran-spermine conjugate is able to form a stable 































I-52 R1 = R2 = H, R3 = CH2CF3













transfection.  The gene transfection efficacy of the vectors was studied in cultured cell 
systems.  Researchers discovered that the transfection efficiency depends on N/P 
(nitrogen of spermine/phosphate of pDNA) ratio.  And Dex-spm shows enhanced 
transfection efficiency only at N/P ratio as high as 5-7.  This technology enables 
researchers to tailor the supramolecular entity very precisely with respect to overall 
transfection efficiency and target specificity by varying the spermine derivative 
conjugated to diverse templates and tagging different target specific ligands to CB[n].   
 
































































































          Before CB[n] can be used for drug delivery purpose, researchers have to prove its 
safety in vivo.  Nau and Day investigated CB[7] and CB[8]’s toxicity in vitro and in 
vivo.39  After testing them in vitro on CHO-K1 cells and in vivo intravenous injection, as 
well as oral administration studies on mice, CB[7] and CB[8] are proved to have a very 
low toxicity.  The mutually consistant IC50 and MTD values suggest that CB[7] is 
essentially nontoxic when applied in concentrations below 250 mg/kg tissue or body 
weight, or below concentrations of 0.5 mM.  Briken and Isaacs recently studied the 
toxicity of several CB[n] and CB[n] type receptors on human cells, which also 
demonstrates very low toxicity.40  These results suggest that CB[n]s are usually safe for 
drug delivery.  
 
1.4 Summary. 
          Since its foundation, supramolecular chemistry has been developing into a very 
important research area both for academia and industry.  Molecular encapsulation with 
cyclodextrin has already been proved to be a very useful technology.  Meanwhile, 
applications of molecular encapsulation with cucurbituril are being developed currently.  
Significant progress has been achieved.  But issues are still existing: 1) poor solubility of 
current CB[n] compared to cyclodextrin; 2) difficulty to functionalize CB[n] for more 
applications.  This thesis will discuss the work that has been done to solve these problems 
by functionalizing CB[n].  Meanwhile, in order to develop new pathways to 
functionalized CB[n], the mechanism of CB[n]  forming reaction is also investigated.     





II. Chapter 2: New CB[n] Congeners with High Affinity. 
 
 2.1 Introduction.   
          As introduced in the Chapter 1, the cucurbit[n]uril (CB[n], n = 5, 6, 7, 8, 10) family 
of molecular containers are formed in a single step by the condensation of glycoluril with 
formaldehyde under strongly acidic conditions.13,15,16,18 The key structural features of 
CB[n] molecular containers are the presence of a hydrophobic cavity guarded by two 
symmetry equivalent ureidyl carbonyl portals which constitute regions of high negative 
electrostatic potential.41,42  As a consequence of these structural features CB[n] 
compounds bind to species which contain both hydrophobic chains and cationic groups.  
In a series of elegant papers throughout the 1980’s Mock showed that CB[6] displays 
tight and highly selective binding interactions toward alkaneammonium and 
alkanediammonium ions in aqueous solution and used these properties to catalyze a 3+2 
dipolar cycloaddition and construct an early example of a molecular switch.43-45  Interest 
in the CB[n] family of molecular containers surged after the isolation of the larger CB[n] 
homologues which displayed even more interesting recognition properties.  For example, 
the exceptionally high binding constants (Ka up to 1015 M-1) displayed by CB[7]46-48 and 
the ability of CB[8] and CB[10] to bind two guests simultaneously has resulted in the a 
number of intriguing applications including the preparation of molecular machines,49 
chemical sensors, stationary phases for chromatographic separations and affinity capture, 





 Despite the range of applications demonstrated for members of the CB[n] family, 
a number of issues have not been fully resolved that currently limit an even wider 
application of the CB[n] family.73  The first issue is the generally poor solubility 
characteristics of CB[6], CB[8], and CB[10] (< 100 µM) in D2O.  A second, related issue 
is that the preparation of CB[n] derivatives especially those with enhanced solubility is 
challenging, particularly for the higher CB[n] homologues (n = 7, 8, 10).24  A final issue 
involves the dynamics of the formation and dissociation of CB[n] complexes.  Because of 
their narrow ureidyl carbonyl portals, CB[n] compounds exhibit constrictive binding.74-78  
In constrictive binding processes, large barriers to dissociation and sometimes association 
exist which translates in kinetics of dissociation and association that are slow on the 
laboratory time scale.  Obviously, slow kinetics can be a limitation in many applications.   
 Over the past decade we have been using mechanistic insights to guide us toward 
synthetic approaches that alleviate some of these limitations.  In one line of inquiry we 
have used glycoluril surrogates to prepare CB[n] analogues with built-in fluorescent 
walls.28,73,79  In a second line of inquiry we have starved the CB[n] forming reaction of 
formaldehyde and isolated acyclic glycoluril oligomers and a number of macrocyclic 
CB[n]-type compounds lacking one or more bridging CH2-groups (known as nor-seco-
CB[n]).20-22,80,81 In a third line of inquiry we have appended o-xylylene walls to glycoluril 
dimers and related systems and delineated the recognition properties (e.g. enantiomeric 
self-recognition, heterochiral recognition, and self-sorting) of the resultant acyclic CB[n] 
congeners.82-84 Recently, Sindelar 20,22,80 has reported the synthesis and recognition 
properties of a glycoluril trimer capped with o-xylylene rings.85  Throughout these studies 





negative ureidyl carbonyl portals decreased the affinity of host toward guest.  In this 
paper we continue the third line of inquiry by preparing hosts II-5a and II-5b which 
comprise a methylene bridged glycoluril tetramer capped with two substituted o-xylylene 
rings and studying their recognition properties toward various ammonium ions in water. 
 
2.2 Results and Discussion.   
          This results and discussion section is organized as follows.  First, we describe the 
design and synthesis of acyclic CB[n] congeners II-5a and II-5b.  Second, we discuss 
their conformational properties, x-ray crystal structures, and verify the absence of self-
association of hosts II-5a and II-5b.  Third, we use a combination of direct and 
competitive UV/Vis spectroscopy and 1H NMR spectroscopy to study the strength and 
geometrical details of the host-guest complexes of hosts II-5a and II-5b.  Lastly, we 
discuss the trends in the tabulated values of Ka that give insights into the behavior of II-
5a and II-5b. 
 
2.2.1 Design and Synthesis of Acyclic CB[n] Congeners II-5a and II-5b.   
          Hosts II-5a and II-5b are composed of a central methylene brided glycoluril 
tetramer that is capped by two o-xylylene rings.  The substituents (e.g. H and Ph or Me) 
on the central methylene bridged glycoluril tetramer all point away from the cavity which 
preorganizes the oligomer into the C-shaped configuration required for binding.  The 





to enable the synthetic route, enhance the solubility of II-5a and II-5b, and potentially 
enhance the binding affinity toward ammonium ions due to additional electrostatic (e.g. 
carboxylate•ammonium) interactions.  The synthesis of the acyclic CB[n] congeners 
follows a building block approach (Scheme II-1).  First, glycoluril bis(cyclic ethers) II-1a 
or II-1b86,87 are reacted with C-shaped dimer II-2C81,88 in MeSO3H at 50 ˚C to yield 
tetramer bis(cyclic ethers) II-3a (35%) and II-3b (53%) in moderate yield.  Compound 
II-3b was reacted with hydroquinone in refluxing TFA to install the HO-substituted o-
xylylene walls to yield II-4.  Compound II-4 was then reacted with ethyl bromoacetate to 
yield an intermediate ester which was directly hydrolyzed to yield host II-5b.  For the 
synthesis of II-5a we allowed II-3a to react with (EtO2CCH2O)2C6H4 under acidic 
conditions (TFA, Ac2O) to yield an intermediate ester which was directly hydrolyzed to 
yield II-5a in moderate yield (32%).  As a control compound to study the influence of the 
substituted o-xylylene walls we decided to prepare methylene bridged glycoluril tetramer 
II-6.  Heating II-3a with 3,5-dimethylphenol as a formaldehyde scavenger73 in refluxing 
TFA delivered II-6 in 45% yield. 
 
Scheme II-1.  Synthesis of Acyclic CB[n] Congeners II-5a and II-5b and tetramer II-6.  




























































II-1a R = Me
























II-3a R = Me













































CH3CN, reflux then LiOH, MeOH / H2O, 70 ˚C then conc. HCl, d) (EtO2CCH2O)2C6H4, 
TFA, Ac2O, reflux then LiOH, MeOH / H2O, 70 ˚C then conc. HCl, e) 3,5-
dimethylphenol, TFA, reflux. 
 
2.2.2 Conformational Properties of II-5a and II-5b.   
          The chemical structures of II-5a and II-5b greatly limit the conformational degrees 
of freedom of the system.  For example, the fused bicyclic glycoluril ring system are 
conformationally locked.  Similarly, the eight-membered rings that connect the 
glycolurils together by methylene bridges adopt the crown conformation which 
minimizes 1,5-diaxial interactions between substitutents on the convex face of the 
glycoluril rings.89,90 Finally, the seven membered ring (7-MR) that connects the terminal 
substituted o-xylylene rings to the glycolurils has the potential to adopt two 
conformations (anti: o-xylylene ring oriented toward the cavity with 7-MR in chair 
conformation; syn: o-xylylene ring oriented away from the cavity with 7-MR in boat 
conformation).  On the basis of previous studies by Nolte91-93 and our group30 we 
anticipated a preference for the anti-conformation (vide infra, Figure II-1a).  In this 
manner, the 15 fused rings of II-5a and II-5b were designed to prefer a single 
conformation that preorganizes these acyclic hosts toward guest binding.  
Macrocyclization is not necessary. 
 






           We were fortunate to obtain single crystals of II-5b in its uncomplexed form 
(Figure II-1a).  As expected based on the precedent described above, II-5b assumes a C-
shaped conformation that defines a hydrophobic cavity.  There are several interesting 
aspects of the structure of II-5b that deserve comment.  First, although the 15 fused rings 
effectively limit the conformation of the molecule to a C-shape, II-5b is able to undergo 
out-of-plane twisting.  Figure II-1a shows that the substituted o-xylylene tips are skewed 
with respect to one another with one residing above the mean plane of the compound and 
the other below.  This out-of-plane skewing results in an overall helical shape of II-5b 
and therefore II-5b assumes a chiral conformation in the crystal.  Within the crystal of II-
5b there are equal amounts of the two enantiomeric forms of II-5b.  Second, the 
OCH2CO2H groups on the o-xylylene rings are oriented roughly parallel to the cavity.  In 
the neutral form of II-5b present in the crystal, the CO2H groups form intramolecular H-
bonds back to the ureidyl C=O portal of II-5b as expected on the basis of its highly 
negative electrostatic potential.  Third, although the chemical structure of II-5b contains 
six units (e.g. four glycolurils and two o-xylylene rings) the cavity of II-5b appears to be 
larger than that of CB[6].  To quantify this effect we consider the distance between the 
quaternary (PhC) carbon atoms on opposite sides of II-5b and CB[n].  The relevant 
distances for II-5b are 11.91 and 12.60Å.  Comparable values for CB[5] are 8.48 and 
7.60, for CB[6] are 10.05 and 10.05, for CB[7] are 10.74 and 11.37 Å, and for CB[8] are 
11.47 and 12.54.  By this measure, the curvature of the methylene bridged glycoluril 
tetramer subunit of II-5b is most similar to that of CB[8].  However, the 7-MR adopt a 
chair-like conformation that projects the connected substituted o-xylylene rings into the 





appears that II-5b contains structural regions that resemble CB[8] and other regions that 
are similar to smaller CB[n]. 
 
Figure II-1.  Cross-eyed stereoviews of the x-ray crystal structures of: a) II-5b, b) II-
5b•II-20, and c) II-5a•II-25.  Color code: C, gray; H, white; N, blue; O, red; H-bonds, 
red-yellow striped. 
 
Figure II-1b shows a stereoview of the x-ray crystal structure of II-5b•II-20.  In this 





C=O•••HN H-bonds and one carboxylic acid C=O•••HN H-bond.  Host II-5b undergoes 
a structural change that decreases the size of the host cavity in the II-5b•II-20 complex.  
This structural change is reflected in the decreased distance between the opposing 
quaternary PhC carbon atoms (11.44 and 11.85 Å).  In addition, one of the terminal o-
xylylene rings of II-5b engages in an offset stacking interaction (mean plane separation = 
3.45 Å; centroid-centroid distance = 3.74 Å) with the aromatic ring of guest II-20.  
Figure II-1c shows a stereoview of the x-ray crystal structure of II-5a•II-25.  Spermine 
II-25 is bound within the cavity of II-5a by virtue of four H-bonds between the central 
NH2 groups of II-25 and the ureidyl C=O groups and the carboxylic acid groups of II-
25.  In addition, each of the terminal N(CH2)NH3+ groups folds back and form an 
additional H-bonds to the C=O portal of II-5a.  In total the II-5a•II-25 complex benefits 
from six H-bonds.  One of the interesting structural features of the II-5a•II-25 complex is 
the pronounced out-of-plane skewing of the terminal o-xylylene rings.  This geometrical 
feature places the CH2-groups of the central butylene linker within the shielding region of 
the adjacent aromatic ring which is reflected in the large upfield shifts observed for Hm 
and Hn in the 1H NMR spectrum of the II-5a•II-25 complex (vide infra).  Overall, hosts 
II-5a and II-5b exhibit a substantial ability to respond to the structural characteristics of 
the guest.  
 
2.2.4 Hosts II-5a, II-5b, and II-6 Do Not Undergo Self-Association.   
          In our previous studies self-association has been an important and in some cases 





recognition properties of II-5a, II-5b, and II-6 we wanted to rule out the possibility of 
self-association in water.   For this purpose we performed 1H NMR dilution experiments 
(Supporting Information) and do not observe any changes in chemical shift over the 60 
µM to 1.52 mM range of concentration.  These results indicate that II-5a, II-5b, and II-6 
do not undergo self-association which allows us to study their host-guest recognition 
properties free of these effects. 
 
2.2.5 Binding Studies Between Hosts II-5a, II-5b, and II-6 and Guests II-7 – II-32.  
          This section describes the non-covalent interaction between the hosts and guests II-
7 – II-30 (Chart II-1) by several different methods. 
 























































































1H NMR Investigations of the Binding Interactions.  Initially, we used 1H NMR to study 
the interaction between II-5b and II-20.  Figure II-2a-c shows the 1H NMR spectra 
recorded for II-5b, II-20, and for an equimolar mixture of II-5b and II-20.  The protons 
on the aromatic ring of II-20 undergo a substantial upfield shift in the presence of II-5b 
which suggests that II-20 is bound within the cavity of II-5b which is corroborated by 
the x-ray crystal structure of II-5b•II-20 (Figure II-1b).  When II-5b and II-20 are mixed 
at a 1:2 stoichiometry we observe resonances for free II-21 and complexed II-21 which 
establishes that the dynamics of exchange are slow on the chemical shift time-scale.  
Attempts to perform 1H NMR titration experiments to determine values of Ka were 
unsuccessful because they exceeded those that can be determined accurately (Ka < 105 M-
1) by this technique.94 Figure II-2d-f shows the 1H NMR recorded for II-5a, spermine II-
25, and an equimolar mixture of II-5a and II-25.  In this case the pattern of upfield shift 
of the resonances for guest II-26 suggests that the central diaminobutane linker of II-25 
is bound within the central cavity of II-5a with the N(CH2)3NH3+ arms extending past the 
ureidyl C=O portals of II-5a.  This interpretation is supported by the x-ray crystal 






Figure II-2.  1H NMR spectra recorded for: a) II-5b, b) II-20, and c) an equimolar 
mixture of II-5b and II-20 (400 MHz, RT, 25 mM sodium phosphate buffered D2O, pH 
7.4) and d) II-5b, e) II-25, f) an equimolar mixture of II-5b and II-25 (600 MHz, RT, 25 
mM sodium phosphate buffered D2O, pH 7.4) 
 
Direct UV/Vis Titrations.  Because the values of Ka for the interaction between II-5a and 
II-20 were inaccessible by 1H NMR titrations we decided to resort to competitive UV/Vis 





1H NMR binding method used by us earlier46 because most of the complexes of II-5a 
display fast exchange kinetics on the chemical shift time scale.  We found that dye II-7 
(Rhodamine 6G) binds to II-5a and undergoes changes in its UV/Vis spectrum.  Figure 
II-3a shows the UV/Vis spectra recorded when a fixed concentration of II-7 (9.23 µM) 
was titrated with II-5a (0 – 49 µM).  The UV/Vis spectra show large changes at 520 and 
550 nm and the presence of an isosbestic point at 533 nm which allowed us to conclude 
that II-5a and II-7 undergo clean formation of the II-5a•II-7 complex.  Figure 3b shows 
a plot of UV/Vis absorbance at 520 nm versus the concentration of II-5a which can be 
fitted to a 1:1 binding model to determine the stability of the II-5a•II-7 complex (Ka = 
2.1 ± 0.1 × 105 M-1).  With this value of Ka in hand it is possible to measure Ka values for 






Figure II-3.  a) UV/Vis spectra obtained during the titration of a fixed concentration of 
II-5a (9.23 µM) with 7 (0 – 49 µM), b) Plot of absorbance versus [II-7] used to 
determine the value of Ka by non-linear least squares fitting, c) Job plot ([II-5a] + [II-7] 
= 1.5 mM) of mole fraction of II-5a versus ΔA × χ. 
 
UV/Vis Indicator Displacement Assays.  In indicator displacement assays, a complex is 
formed between a host and an indicator that undergoes an UV/Vis change upon 
complexation.  Upon addition of a competitive binding guest, the indicator is released 
resulting in a UV/Vis spectral change.  Based on a knowledge of the concentrations 





interaction it is possible to calculate the unknown Ka.  We used this strategy with dyes 
(indicators) II-7 and II-8 to determine the values of Ka for the complexes between host 
II-5a and guests II-9–II-30 (Table II-1).  We first used the competition between non-
UV/Vis active guest butylammonium ion II-26 and rhodamine G (II-7) to determine the 
stability of the II-5a•II-26 complex (Ka = 1.4 ± 0.1 × 105 M-1).  Subsequently we 
performed an indicator displacement assay between II-5a, UV/Vis active acridine dye II-
8, and II-26 which allowed us to determine the value of Ka for the II-5a•II-8 complex 
(Ka = 7.2 ± 0.4 × 108 M-1).  We then measured the values of Ka for the remaining 
complexes of II-5a by indicator displacement assays using the II-5a•II-8 complex (Table 
II-1).  The data from the UV/Vis competition assays and their analysis to extract the Ka 
values are given in the supporting information section of this chapter.  Table II-1 also 
presents the literature values of the binding constants for a subset of these guests toward 
CB[6]45 and CB[7].46 
 Ka (M-1) 
Guests Host II-5a CB[6]a) CB[7]b) 
II-7 2.1 ± 0.1 × 105   
II-8 7.2 ± 0.4 × 108   
II-9 1.4 ± 0.1 × 106 1.5 × 105  
II-10 2.8 ± 0.3 × 107 2.4 × 106  
II-11 1.6 ± 0.1 × 108 2.8 × 106 
4.5 ± 0.8 × 108 b) 
9.0 ± 1.4 × 107 
II-12 1.4 ± 0.1 × 108 4.3 × 104  
II-13 3.6 ± 0.4 × 108 9.1 × 103  
II-14 2.2 ± 0.2 × 108 4.8 × 102  
II-15 2.0 ± 0.2 × 108 1.0 × 102  
II-16 7.2 ± 0.7 × 107   
II-17 3.2 ± 0.3 × 107   
II-18 4.3 ± 0.4 × 107  2.3 ± 0.4 × 107 
II-19 7.1 ± 0.8 × 105  2.1 ± 0.3 × 106 
II-20 6.8 ± 0.9 × 108  1.8 ± 0.3 × 109 
II-21 4.0 ± 0.4 × 108  1.3 ± 0.2 × 107 
II-22 3.5 ± 0.4 × 106  4.2 ± 1.0 × 1011 





II-24 2.6 ± 0.4 × 107 1.4 × 106  
II-25 4.5 ± 0.4 × 108 1.3 × 107  
II-26 1.4 ± 0.1 × 105 1.0 × 105  
II-27 1.4 ± 0.1 × 106 2.2 × 103  
II-28 3.6 ± 0.5 × 109   
II-29 2.0 ± 0.2 × 109   
II-30 9.8 ± 0.9 × 107 9.1 × 103  
II-31 3.1 ± 0.4 × 108 1.7 × 106  
II-32 1.4 ± 0.2 × 108   
(a) Measured in H2O/85% HCO2H (1:1),44 b) Measured in 50 mM NaOAc buffer,pH 
4.74.45 
Table II-1. Binding constants (Ka) for the interaction of II-5a and various guests. 
 
2.2.6 Trends in the Values of Ka Between Host II-5a and Guests.  The values of Ka 
given in Table II-1 allow us to make comparisons between various guests that shed light 
on the overall binding properties of II-5a compared other CB[n]. 
Influence of Chain Length.  One of the best studied phenomena in the binding properties 
of the CB[n] family is the influence of guest length on the binding affinity of 
alkanediammonium ions. For the relatively rigid host CB[6] a maximum binding affinity 
is seen for pentanediammonium and hexanediammonium ions II-10 and II-11 with 
greatly reduced affinity toward longer and shorter diammonium ions.45  Figure II-4 shows 
a plot of binding affinity of II-5a and CB[6] toward diammonium ions II-9 – II-17 as a 
function of chain length.  Several trends in this data are worth noting.  First, host II-5a 
binds more tightly to many of these alkanediammonium ions than CB[6] does.  These 
higher binding constants may reflect: 1) that the larger hydrophobic cavity of II-5a 
(relative to CB[6]) provides a larger hydrophobic driving force toward complexation, 





5a and the diammonium guest (vide infra).  Second, host II-5a appears to be less 
sensitive to changes in length than CB[6]; host II-5a is less selective than CB[6] and 
binds II-11 – II-15 with high affinity (Ka > 108 M-1).  We believe this lower selectivity is 
due to the structural flexibility of host II-5a relative to CB[6].  For example, when host 
II-5a adopts a skewed (helical) conformation the distance between its ureidyl C=O 
portals also change.  It is well known that the ureidyl C=O portals of CB[n] provide a 
significant portion of the driving force for the binding of ammonium ions by ion-dipole / 
H-bonding interactions.  Similarly, host II-5a is acyclic which allows it to increase its 
cavity size by flexing its pairs of CH2-bridges.  This process allows II-5a to 
accommodate longer guests perhaps by folding the hydrophobic chain of the guest inside 
the host.22,97 
 
Figure II-4.  Plot of log (Ka) versus chain length for the interaction between 
alkanediammonium ions (II-9 – II-17) and hosts II-5a (•) or CB[6] (■). 
 
Binding Capacity of II-5a.  Based on the analysis of the x-ray structure of II-5a (Figure 





decanediammonium ion II-15) we anticipated that host II-5a would be able to complex 
larger guests that typically only bind to the more spacious hosts CB[7] and CB[8].  For 
this purpose, we studied the binding affinity of II-5a toward guests II-18 – II-23 which 
display a range of guest sizes.  For example, CB[6] binds to the smaller guests II-19 and 
II-20, CB[7] can accommodate slightly larger guests II-18, II-21, and II-22, and CB[8] 
is able to bind tightly even to dimethyl adamantaneammonium ion II-23.46  In contrast, 
host II-5a forms complexes with all six size probe guests II-18 – II-23 albeit with 
differences in affinity.  For example, host II-5a binds relatively weakly to the smallest 
(II-19, Ka = 7.1 × 105 M-1) and largest (II-23, Ka = 4.8 × 105 M-1) guests in this series.  
The intermediate sized guests II-18, II-20, and II-21 are all bound more tightly by II-5a.  
These higher levels of affinity may be due to a better size match between the cavity of 
host II-5a and guests II-18, II-20, and II-21, the possibility of-interactions between 
guests II-20 or II-21 and the substituted o-xylylene walls of host II-5a, or a combination 
of these factors.  In combination these results suggest that the effective cavity volume of 
II-5a is similar to or slightly larger than that of CB[7] (V = 272 Å3).42  It is worth noting 
that the affinity of II-5a toward several of these size probe guests (II-18, II-21, and II-
23) exceeds the Ka values measured toward CB[7] (Table II-1).  In contrast, the affinity 
of CB[7] toward its best guests (II-20 and II-22) is greater than that measured toward II-
5a.  These results reinforce our belief that the flexibility of II-5a makes it a more general 
purpose high affinity but modest selectivity host in water. 
Effect of the Number of Ammonium Groups.  In his pioneering work Mock demonstrated 
that the addition of ammonium groups to guests for CB[6] generally resulted in a 10 – 





spermine II-25 (Ka = 1.3 × 107 M-1) binds ≈ 10-fold stronger to CB[6] than spermidine 
II-24 (Ka = 1.4 × 106 M-1), which in turn binds ≈ 10-fold stronger to CB[6] than 
butanediammonium ion (II-9, Ka = 1.5 × 105 M-1) does.  The values of Ka contained in 
Table II-1 allow us to ascertain whether similar trends hold for II-5a.  For example, 
butylammonium ion (II-26, Ka = 1.4 × 105 M-1) binds 10-fold weaker to II-5a than 
butanediammonium ion (II-9, Ka = 1.4 × 106 M-1) does.  Similarly, hexylammonium ion 
(II-27, Ka = 1.4 × 106 M-1) binds ≈ 100-fold weaker to II-5a than hexanediammonium 
ion (II-11, Ka = 1.6 × 108 M-1).  Related trends (5-fold increase in Ka per ammonium 
group) can be seen when comparing the binding of butanediammonium ion (II-9, Ka = 
1.4 × 105 M-1) with triammonium ion spermidine II-24 (Ka = 2.6 × 107 M-1) and 
tetraammonium ion spermine II-25 (Ka = 4.5 × 108 M-1).  Acyclic CB[n] congener II-5a 
displays similar gains in Ka as a result of additional ammonium groups as CB[6] does. 
Effect of the Degree of Alkylation of the Ammonium Ion.  The affinity of CB[6] toward 
alkanediammonium ions is dramatically effected by the degree of alkylation of the N-
atoms.  For example, CB[6] binds tightly to hexanediammonium ion II-11 (Ka = 2.8 × 
106 M-1) and N,N’-dimethylhexanediammonium ion II-31 (Ka = 1.7 × 106 M-1) but binds 
only weakly to N,N,N’,N’-tetramethylhexanediammonium ion II-30 (Ka = 9.1 × 103 M-
1).  This effect can be explained based on the geometry of the CB[6]•II-11 complex 
which displays two N-H•••O=C H-bonds per portal.  Accordingly, each ammonium ion 
can have two C-subsitutents and 2 H-atoms and still assume this ideal geometry; addition 
of a third C-subsitutent (e.g. II-30) results in severe steric interactions between host and 
guest.  The affinity of II-5a toward II-11 (Ka = 1.8 × 108 M-1), II-31 (Ka = 3.1 × 108 M-1), 





The comparable affinities of II-5a toward II-11, II-31, II-30, and II-32 suggests that the 
flexibility of II-5a allows it to compensate for the loss of N-H•••O=C H-bonds by an 
increased hydrophobic driving force for the inclusion of the additional alkyl groups in the 
cavity of II-5a. 
Effect of the Concentration of Buffer Used.  It is well known from CB[n] supramolecular 
chemistry that the presence of metal cations in solution reduces their apparent binding 
affinity toward guests due to competitive binding at the electrostatically negative ureidyl 
C=O lined portals.30,78,98-100  We hypothesized that the ureidyl C=O portals of acyclic 
CB[n] congeners II-5a and II-5b which are shaped by four contiguous glycoluril units 
should also bind to metal cations and thereby reduce their affinity toward guests.  
Accordingly, we measured the affinity of rhodamine 6G (II-7) toward II-5b by direct 
UV/Vis titration in sodium phosphate buffer (pH 7.4) at different concentrations.  Figure 
II-5 shows a plot of Ka versus phosphate concentration.  As the concentration of sodium 
phosphate is increased the log Ka value undergoes a steady decrease as expected based 
on competitive binding of Na+ for the C=O portals of II-5b.  This analysis indicates that 
the ureidyl C=O portal of host II-5b retains this essential feature of the CB[n] family 







Figure II-5.  Plot of log Ka versus the concentration of sodium phosphate buffer (H2O, 
pH 7.4) for the formation of the II-5b•II-7 complex. 
 
Contribution of the substituted o-xylylene walls to the binding.  Based on the excellent 
binding affinity of II-5a toward the aromatic guests II-8, II-20, II-21, II-28, and II-29  
and the x-ray structure of II-5b•II-20 (Figure II-1b) we suspected that interactions 
between the substituted o-xylylene walls of II-5a and the aromatic rings of the guest 
might be an important driving force in the recognition behavior of host II-5a.  
Accordingly, we prepared compound 6 which lacks the substituted o-xylylene walls of 
II-5a.  We measured the value of Ka for the interaction between II-6 and 
hexanediammonium ion (II-11, Ka = 5.6 ± 0.4 × 103 M-1) or p-xylenediammonium ion 
(II-20, Ka = 1.5 ± 0.1 × 104 M-1) by direct 1H NMR titrations (Supporting Information).  
These Ka values are greater than substantially smaller than the corresponding values for 
the interaction of II-5a with II-11 (Ka = 1.6 ± 0.1 × 108 M-1) and II-20 (Ka = 6.8 ± 0.9 × 
108 M-1).  This indicates that the substituted o-xylylene walls of II-5a do contribute 
substantially to the overall binding behavior of II-5a.  The fact that reduction in affinity 





fold) suggests that the aromatic walls do not participate in strong specific interactions but 
instead probably enhance binding by defining a structured environment from which water 
can be released upon binding.  To ascertain the potential contributions of carboxylate-
ammonium ion electrostatic interactions on the recognition behavior of II-5a we 
compared its binding toward II-28 and II-29.  Both II-28 and II-29 are derivatives of p-
xylylene diamine; II-29 contains two CH2CH2CH3 arms whereas II-28 contains two 
CH2CH2NH3+ arms.  We specifically chose the two carbon linkers to prevent backfolding 
of the CH2CH2NH3+ arms to the ureidyl C=O portals of II-5a and potentially promote 
carboxylate-ammonium ion electrostatic interactions in the II-5a•II-28 complex.  
Experimentally, we find that the binding constants measured for II-5a•II-28 and II-5a• 
II-29 are quite similar which suggests that carboxylate•ammonium ion electrostatic 
interactions do not play a large role in the recognition behavior of II-6 and II-5a. 
 
2.3 Conclusions. 
          In summary, we have presented the synthesis of acyclic CB[n] congeners II-5a and 
II-5b that contain four contiguous methylene bridged glycoluril units.  Despite the 
acyclic nature of II-5a and II-5b the 15 fused rings effectively pre-organizes II-5a and 
II-5b into a C-shape required for binding.  By a combination of direct UV/Vis titrations 
along with indicator displacement assays we determined the values of Ka for the 
interaction of II-5a with a variety of guest compounds (II-7 – II-32).  We find that II-5a 
acts as a high affinity host – just like CB[n] – with binding constants in the 105 – 109 M-1 





II-5a displays only moderate levels of selectivity based on guest length and the degree of 
alkylation of the N-atoms of the ammonium ion guests.  We attribute this lower 
selectivity to the conformational changes of the host that occur upon formation of the 
host•guest complexes.  Similar to CB[n], the binding affinity of II-5a toward its guests 
increases by a factor of 10 – 1000 as the number of ammonium ions in the guests is 
increased (e.g. II-9 vs. II-24 vs. II-25) whereas the affinity is reduced as the 
concentration of metal cations in the buffer increases due to competitive binding at the 
ureidyl C=O portals. 
 To date, three major issues for the use of CB[n] compounds in practical 
applications have been: 1) their generally poor solubility in aqueous solution, 2) 
challenges for their selective functionalization, and 3) the relatively slow uptake and 
release rates of guests due to the constrictive binding nature of the CB[n] cavity.  The 
acyclic CB[n] congeners presented in this paper were prepared by convergent building 
block routes and feature terminal o-xylylene rings that are readily functionalized and 
endowed with carboxylic acid groups that increase solubility in aqueous solution.  By 
virtue of its fused ring acyclic structure II-5a is both preorganized for ammonium ion 
binding and capable of fast uptake and release of its guests.  Macrocyclization is not 
necessary to achieve high affinity interactions between acyclic CB[n] congeners and 
ammonium ion guests.  The availability of acyclic CB[n] congeners that can be readily 
functionalized while maintaining the outstanding recognition properties of the CB[n] 
family promises their future use in a variety of applications including chemical sensing, 






2.4 Experimental Section. 
General Experimental. Starting materials were purchased from commercial suppliers and 
were used without further purification. Compounds II-1a, II-1b, II-2C, II-28 and II-29 
were prepared according to literature procedures.81,86,87,101,102 Melting points were 
measured on a Meltemp apparatus in open capillary tubes and are uncorrected.  TLC 
analysis was performed using pre-coated plastic plates from Merck.  IR spectra were 
recorded on a JASCO FT/IR 4100 spectrometer and are reported in cm-1.  NMR spectra 
were measured on a Bruker DRX-400 instrument operating at 400 MHz for 1H and 100 
MHz for 13C.  Mass spectrometry was performed using a JEOL AccuTOF electrospray 
instrument (ESI). 
 
Compound II-3a: To a mixture of II-2C (7.42 g, 24.0 mmol) in anhydrous MeSO3H (55 
mL), II-1a (24.46 g, 96.2 mmol) was added.   The mixture was stirred and heated at 50 
oC for 3 h.  The reaction mixture was poured into water (700 mL).  After filtration, the 
crude solid was dried in high vacuum.  The crude solid was recrystallized from TFA (15 
mL) and water (45 mL) to yield II-3a as a white solid (6.60 g, 8.45 mmol, 35%).  M.p. > 
227 oC (decomposed). IR (ATR, cm-1):1714s, 1456m, 1314m, 1223s, 1177s, 1079m, 
960m, 920m, 857m, 799s, 757m, 668m.  1H NMR (400 MHz, DMSO-d6): 5.64 (d, J = 
14.0, 2H), 5.50 (d, J = 15.1, 4H), 5.50 (d, J = 11.0, 2H), 5.37 (d, 1 J = 8.6, 2H), 5.25 (d, 
J = 11.0, 2H), 5.12 (d, J = 11.7, 4H), 4.78 (d, J =11.0, 4H), 4.20 (d, J = 14.8, 4H), 4.16 
(d, J = 12.5, 2H), 1.72 (d, J = 69.6, 12H).  13C NMR (100 MHz, TFA, 1, 4-dioxane as 
internal reference): δ 157.0, 156.6, 78.5, 74.5, 71.2, 71.0, 70.6, 52.3, 48.1, 15.5, 14.4.  





Compound II-3b: A mixture of II-2C (0.920 g, 3.00 mmol) and II-2b (2.61 g, 6.90 mmol) 
in MeSO3H (10 mL) was stirred at room temperature for 20 min.  Then the mixture was 
stirred and heated at 50 oC for 4 hours.  The reaction mixture was poured into MeOH 
(500 mL). After filtration, the crude solid was dried in high vacuum.  The crude solid was 
recrystallized from TFA (25 mL) and water (25 mL) to yield II-3b as a white solid (1.700 
g, 1.65 mmol, 53%).  M. P. >350 °С.  TLC (MeCN/H2O, 4:1) Rf 0.47.  IR (cm-1): 3450w, 
1722s, 1445m, 1362m, 1314m, 1198s.  1H-NMR (400 MHz, DMSO-d6): 7.14-6.95 (m, 
20H), , 5.82 (d, J = 15.2, 4H), 5.68 (d, J = 14.2, 2H), 5.38 (d, J = 10.8, 4H), 5.20 (d, J = 
10.2, 2H), 5.03 (d, J = 8.4, 2H), 4.30 (d, J = 10.8, 4H), 4.08 (d, J = 14.2, 2H), 4.05 (d, J = 
15.2, 4H)  13C NMR (100 MHz, TFA, 1, 4-dioxane as internal reference): δ 159.6, 157.5, 
130.7, 130.3, 129.6, 128.9, 128.3, 128.2, 127.4, 87.8, 81.9, 72.3, 72.0, 71.6, 53.2, 50.6.  
MS (ESI): m/z 1029 ([M + H]+).  
Compound II-4: A mixture of II-3b (4.18 g, 4.06 mmol) and hydroquinone (7.15 g, 65.0 
mmol) in TFA (60 mL) was heated at reflux for 10 hours.  The solvent was removed by 
rotary evaporation.  The solid was washed twice with MeOH (2 × 70 mL) and then hot 
DMSO (15 mL). The solid was obtained by filtration and dried under high vacuum to 
yield II-4 as a white solid (2.90 g, 2.39 mmol, 59%).  M. P. >350 °С (decomposed).  IR 
(cm-1): 3400w, 1722s, 1448s, 1194s.  1H-NMR (400 MHz, DMSO-d6): 8.70 (s, 4H), 7.09-
6.77 (m, 24H), 6.53 (s, 4H), 5.77 (d, J = 14.4, 4H), 5.54 (d, J = 15.2, 2H), 5.32 (d, J = 
15.8, 4H), 5.10 (d, J = 8.0, 2H), 4.89 (d, J = 8.0, 2H), 3.96 (d, J = 14.0, 2H), 3.88 (d, J = 
14.4, 4H), 3.72 (d, J = 15.5, 4H).  13C NMR (100 MHz, TFA, 1, 4-dioxane as internal 
reference): δ. 159.4, 156.6, 146.2, 130.1, 130.0, 129.7, 129.0, 128.8, 128.0, 127.1, 125.1, 





Compound II-5a: To a mixture of II-5a (6.56 g, 8.36 mmol) and II-4 (17.9 g, 66.9 
mmol) in TFA (40 mL), Ac2O (6.30 mL, 66.9 mmol) was added.  The mixture was 
heated at reflux for 2 h.  The solvent was removed by rotary evaporation.  The solid was 
washed twice with diethyl ether (2 × 200 mL). Filtration and drying on high vacuum gave 
a white solid. This white solid was mixed with LiOH (1.70 g, 70.8 mmol) and dissolved 
in MeOH and water (1:1, v/v, 400 mL).  The mixture was heated at 80 ˚C for 15 h.  The 
solvent was removed by rotary evaporation. The crude solid was dissolved in water (60 
mL) and treated with conc. HCl (14 mL).  The solid was obtained by filtration, dried on 
high vacuum and then recrystallized with TFA (40 mL) and water (120 mL) to yield II-
5a as a white solid (3.2 g, 2.65 mmol, 32%). M.p. > 310 ˚C (dec.).  IR (ATR, cm-1): 
1707s, 1477m, 1313m, 1200m, 964m, 785s.  1H NMR (400 MHz, DMSO-d6): 6.74 (s, 
4H), 5.56 (d, J = 14.8, 2H), 5.46 (d, J = 14.8, 4H), 5.35 (d, J = 9.6, 2H), 5.25 (d, J = 
15.6, 4H), 5.24 (d, J = 9.6, 2H), 4.65 (m, 8H), 4.13 (d, J = 15.6, 4H), 4.03 (d, J = 14.8, 
4H), 4.03 (d, J = 14.8, 2H), 1.65 (s, 6H), 1.63 (s, 6H).  13C NMR (100 MHz, TFA, 
DMSO-d6 as internal reference): δ 175.7, 157.0, 156.6, 149.5, 127.4, 113.7, 79.9, 78.3, 
72.0, 71.4, 65.8, 53.2, 48.4, 35.0, 15.1, 14.3.  HR-MS (ESI): m/z 1197.3548 ([M + H]+), 
calculated 1197.3622. 
Compound II-5b: A mixture of II-4b (2.90 g, 2.39 mmol), ethyl bromoacetate (3.20 g, 
19.1 mmol) and anhydrous K2CO3 (6.62 g, 48.0 mmol) in MeCN (300 mL) was heated at 
reflux for 10 hrs. Solvent was removed under reduced pressure. Crude product was 
extracted with acetone (70 mL×3). After the solvent was removed with rotary 
evaporation, the crude product was washed with ethyl acetate (15 mL) to yield a white 





dissolved in MeOH and water mixture (1:1, v/v, 120 mL). The mixture was heated at 80 
oC for 15 hrs. Solvent was removed with rotovapory evaporation. The crude solid was 
treated with water (60 mL) and conc. HCl (1.6 mL, 19.2 mmol) and then filtered to yield 
II-5b as a white solid (1.7 g, 1.2 mmol, 50%).  M.p. > 248 ˚C (dec.).  IR (ATR, cm-1): 
1713s, 1462s, 1380m, 1315m, 1224s, 1196s, 1094m, 971s, 863m, 801m, 696m.  1H NMR 
(400 MHz, D2O): 7.02-6.81 (m, 20H), 6.57 (s, 4H), 5.71 (d, J = 16.0, 4H), 5.58 (d, J = 
15.2, 2H), 5.21 (d, J = 8.8, 2H), 5.09 (d, J = 15.2, 4H), 4.93 (d, J =8.8, 2H), 4.31 (d, J = 
15.6, 4H), 4.28 (d, J = 15.2, 4H), 4.18 (d, J = 15.6, 4H), 4.10 (d, J = 16.0, 4H), 3.99 (d, J 
= 15.2, 2H).  13C NMR (100 MHz, TFA, 1, 4-dioxane as internal reference): δ 173.7, 
157.5, 155.0, 148.0, 128.3, 128.04, 127.3, 127.1, 126.3, 126.1, 125.4, 125.3, 112.4, 86.3, 
85.3, 70.6, 69.6, 64.2, 52.2, 48.5, 35.3.  HR-MS (ESI): m/z 1445.4252 ([M + H]+), 
calculated 1445.4248. 
Compound II-6: A mixture of II-3a (3.95 g, 5.06 mmol) and 3, 5-dimethyl phenol (2.50 
g, 20.5 mmol) in TFA (10 mL) was heated at reflux for 1 h.  The solvent was removed 
with rotovapory evaporation.  The crude solid was washed with MeOH (50 mL).  The 
product was extracted with conc. HCl (150 mL) to yield II-6 as a white solid (1.5 g, 2.25 
mmol, 45%).  M.p. > 281 oC (decomposed).  IR (ATR, cm-1): 1711s, 1455s, 1376m, 
1221s, 1073m, 972m, 797s, 757m, 667m.  1H NMR (400 MHz, D2O): 5.65 (d, J = 15.5, 
2H), 5.50 (d, J = 15.9, 4H), 5.42 (s, 4H), 4.15 (d, J = 16.6, 6H), 1.56 (s, 6H), 1.39 (s, 
6H).  13C NMR (100 MHz, 35% DCl): δ 155.8, 154.1, 79.3, 73.3, 68.0, 67.6, 49.4, 45.5, 






2.5 Supporting Information 
 





Figure II-S2. 13C NMR spectrum (100 MHz, TFA, DMSO-d6 as internal reference) 












Figure II-S4. 13C NMR spectrum (100 MHz, TFA, DMSO-d6 as internal reference) 













Figure II-S6. 13C NMR spectrum (100 MHz, TFA, DMSO-d6 as internal reference) 












Figure II-S8. 13C NMR spectrum (100 MHz, TFA, DMSO-d6 as internal reference) 













Figure II-S10. 13C NMR spectraum (100 MHz, TFA, 1, 4-dioxane as internal reference) 














Figure II-S12. 13C NMR spectrum (100 MHz, 35% DCl, 1, 4-dioxane as internal 





Determination of binding constants: 
1:1 Binding Models Used in Scientist.  
All calculations were performed on a personal computer running Scientist. 
 
Models used to calculate the binding constant of dyes and II-5a or II-5b. 
 
// Micromath Scientist Model File 
// 1:1 Host:Guest binding model 
//This model assumes the guest concentration is fixed and host concentration is varied 
IndVars: ConcHostTot 
DepVars: SpectroscopicSignal 
Params: Ka, ConcGuestTot, SpectroscopicSignalMin, SpectroscopicSignalMax 
Ka = ConcHostGuest/(ConcHostFree*ConcGuestFree) 
ConcHostTot=ConcHostFree + ConcHostGuest 
ConcGuestTot=ConcGuestFree + ConcHostGuest 
SpectroscopicSignal = SpectroscopicSignalMin + (SpectroscopicSignalMax - 
SpectroscopicSignalMin) * (ConcHostGuest/ConcGuestTot) 
//Constraints 
0 < ConcHostFree < ConcHostTot 
0 < Ka 
0 < ConcGuestFree < ConcGuestTot 
0 < ConcHostGuest < ConcHostTot 
 







// MicroMath Scientist Model File 
IndVars: ConcAntot 
DepVars: Absorb 
Params: ConcHtot, ConcGtot, Khg, Kha, AbsorbMax, AbsorbMin 
Khg = ConcHG / (ConcH * ConcG) 
Kha = ConcHAn / (ConcH * ConcAn) 
Absorb = AbsorbMin + (AbsorbMax-AbsorbMin)*(ConcHG/ConcGtot) 
ConcHtot = ConcH + ConcHG + ConcHAn 
ConcGtot = ConcHG + ConcG 
ConcAntot = ConcAn + ConcHAn 
0 < ConcHG < ConcHtot 
0 < ConcH < ConcHtot 
0 < ConcG < ConcGtot 
0 < ConcAn < ConcAntot 
*** 
 
Models used to calculate the binding constant of guests II-11 and II-20 with host II-6 
using NMR titration. 
 
// Micromath Scientist Model File 
// 1:1 Host:Guest binding model for NMR 
//This model assumes the guest concentration is fixed and host concentration is varied 
IndVars: ConcHostTot 
DepVars: Deltaobs 





Ka = ConcHostGuest/(ConcHostFree*ConcGuestFree) 
ConcHostTot=ConcHostFree + ConcHostGuest 
ConcGuestTot=ConcGuestFree + ConcHostGuest 
Deltaobs = Deltazero + (Deltasat - Deltazero) * (ConcHostGuest/ConcGuestTot) 
//Constraints 
0 < ConcHostFree < ConcHostTot 
0 < Ka 
0 < ConcGuestFree < ConcGuestTot 


























Figure II-S13. (A) UV/Vis spectra from the titration of dye II-7 (9.23 µM) with II-5a (0 
– 48 µM) in 20 mM NaH2PO4 buffer (pH 7.4); (B) plot of the ΔA550 as a function of II-
5a concentration. The solid line represents the best non-linear fit of the data to a 1:1 









Figure II-S14. Displacement titration of a solution of dye II-7 (9.23 µM) and II-5a (7.28 
µM) solution with II-26 (0 – 0.15 mM) (20 mM NaH2PO4 buffer, pH 7.4): (A) spectral 
change, (B) Non-linear fitting plot of absorbance versus concentration for the 









Figure II-S15. Displacement titration of a solution of dye II-8 (18.62 µM) and II-5a 
(17.04 µM) solution with II-26 (0 – 0.14 M) (20 mM NaH2PO4 buffer, pH 7.4): (A) 
spectral change, (B) Non-linear fitting plot of absorbance versus concentration for the 









Figure II-S16. Displacement titration of a solution of dye II-8 (17.77 µM) and II-5a 
(13.16 µM) solution with II-9 (0 - 65 mM) (20 mM NaH2PO4 buffer, pH 7.4): (A) 
spectral change, (B) Non-linear fitting plot of absorbance versus concentration for the 









Figure II-S17. Displacement titration of a solution of dye II-8 (21.75 µM) and II-5a 
(18.83 µM) solution with II-10 (0 – 3.6 mM) (20 mM NaH2PO4 buffer, pH 7.4): (A) 
spectral change, (B) Non-linear fitting plot of absorbance versus concentration for the 









Figure II-S18. Displacement titration of a solution of dye II-8 (17.77 µM) and II-5a 
(13.16 µM) solution with II-11 (0 - 550 µM) (20 mM NaH2PO4 buffer, pH 7.4): (A) 
spectral change, (B) Non-linear fitting plot of absorbance versus concentration for the 









Figure II-S19. Displacement titration of a solution of dye II-8 (21.75 µM) and II-5a 
(18.82 µM) solution with II-12 (0 - 305 µM) (20 mM NaH2PO4 buffer, pH 7.4): (A) 
spectral change, (B) Non-linear fitting plot of absorbance versus concentration for the 









Figure II-S20. Displacement titration of a solution of dye II-8 (21.75 µM) and II-5a 
(18.83 µM) solution with II-13 (0 - 230 µM) (20 mM NaH2PO4 buffer, pH 7.4): (A) 
spectral change, (B) Non-linear fitting plot of absorbance versus concentration for the 









Figure II-S21. Displacement titration of a solution of dye II-8 (21.75 µM) and II-5a 
(18.83 µM) solution with II-14 (0 - 230 µM) (20 mM NaH2PO4 buffer, pH 7.4): (A) 
spectral change, (B) Non-linear fitting plot of absorbance versus concentration for the 









Figure II-S22. Displacement titration of a solution of dye II-8 (21.75 µM) and II-5a 
(18.83 µM) solution with II-15 (0 - 365 µM) (20 mM NaH2PO4 buffer, pH 7.4): (A) 
spectral change, (B) Non-linear fitting plot of absorbance versus concentration for the 








Figure II-S23. Displacement titration of a solution of dye II-8 (21.75 µM) and II-5a 
(18.83 µM) solution with II-16 (0 – 1.55 mM) (20 mM NaH2PO4 buffer, pH 7.4): (A) 
spectral change, (B) Non-linear fitting plot of absorbance versus concentration for the 









Figure II-S24. Displacement titration of a solution of dye II-8 (21.75 µM) and II-5a 
(18.83 µM) solution with II-17 (0 – 2.1 mM) (20 mM NaH2PO4 buffer, pH 7.4): (A) 
spectral change, (B) Non-linear fitting plot of absorbance versus concentration for the 









Figure II-S25. Displacement titration of a solution of dye II-8 (17.77 µM) and II-5a 
(13.16 µM) solution with II-18 (0 – 1.85 mM) (20 mM NaH2PO4 buffer, pH 7.4): (A) 
spectral change, (B) Non-linear fitting plot of absorbance versus concentration for the 









Figure II-S26. Displacement titration of a solution of dye II-7 (8.32 µM) and II-5a (9.09 
µM) solution with II-19 (0 - 140 µM) (20 mM NaH2PO4 buffer, pH 7.4): (A) spectral 
change, (B) Non-linear fitting plot of absorbance versus concentration for the 









Figure II-S27. Displacement titration of a solution of dye II-8 (17.77 µM) and II-5a 
(13.16 µM) solution with II-20 (0 - 45 µM) (20 mM NaH2PO4 buffer, pH 7.4): (A) 
spectral change, (B) Non-linear fitting plot of absorbance versus concentration for the 









Figure II-S28. Displacement titration of a solution of dye II-8 (17.77 µM) and II-5a 
(13.16 µM) solution with II-21 (0 - 460 µM) (20 mM NaH2PO4 buffer, pH 7.4): (A) 
spectral change, (B) Non-linear fitting plot of absorbance versus concentration for the 









Figure II-S29. Displacement titration of a solution of dye II-8 (10.87 µM) and II-5a 
(9.41 µM) solution with II-22 (0 – 8.2 mM) (20 mM NaH2PO4 buffer, pH 7.4): (A) 
spectral change, (B) Non-linear fitting plot of absorbance versus concentration for the 









Figure II-S30. Displacement titration of a solution of dye II-8 (18.62 µM) and II-5a 
(17.04 µM) solution with II-23 (0 – 0.12 M) (20 mM NaH2PO4 buffer, pH 7.4): (A) 
spectral change, (B) Non-linear fitting plot of absorbance versus concentration for the 









Figure II-S31. Displacement titration of a solution of dye II-8 (17.77 µM) and II-5a 
(13.16 µM) solution with II-24 (0 – 2.7 mM) (20 mM NaH2PO4 buffer, pH 7.4): (A) 
spectral change, (B) Non-linear fitting plot of absorbance versus concentration for the 









Figure II-S32. Displacement titration of a solution of dye II-8 (17.77 µM) and II-5a 
(13.16 µM) solution with II-25 (0 - 250 µM) (20 mM NaH2PO4 buffer, pH 7.4): (A) 
spectral change, (B) Non-linear fitting plot of absorbance versus concentration for the 









Figure II-S33. Displacement titration of a solution of dye II-7 (9.23 µM) and II-5a (7.28 
µM) solution with II-27 (0 - 73 µM) (20 mM NaH2PO4 buffer, pH 7.4): (A) spectral 
change, (B) Non-linear fitting plot of absorbance versus concentration for the 









Figure II-S34. Displacement titration of a solution of dye II-8 (17.96 µM) and II-5a 
(12.28 µM) solution with II-29 (0 - 93 µM) (20 mM NaH2PO4 buffer, pH 7.4): (A) 
spectral change, (B) Non-linear fitting plot of absorbance versus concentration for the 









Figure II-S35. Displacement titration of a solution of dye II-8 (17.77 µM) and II-5a 
(13.16 µM) solution with II-30 (0 - 570 µM) (20 mM NaH2PO4 buffer, pH 7.4): (A) 
spectral change, (B) Non-linear fitting plot of absorbance versus concentration for the 





Sample Determination of Krel for the Competition Between II-20 and II-28 for II-5a. 
We use equation 1 to determine Krel for the interaction of II-20 and II-28 for II-5a. For 
this purpose, we prepared a solution containing II-5a (1.44 mM), II-20 (3.48 mM), II-28 
(1.92 mM) and reference (1, 3, 5-benzene tricarboxylic acid, 0.88 mM) and allowed it to 
reach equilibrium (Figure XX). Next, we determined the concentration of II-5a• II-28 by 
integration of the appropriate resonances in the 1H NMR spectrum compared to reference 
(Figure II-S36: II-5a• II-28: 5.97 ppm; reference: 8.23 ppm). Using the concentration 
and the mass balance expression (equation 2) allowed us to calculate [II-28]free = 1.00 
mM and [II-5a• II-28] = 0.918 mM. Equation 3 
is then used to calculate [II-5a• II-20] (0.518 mM) using the known value of II-5a• II-
28. Lastly, equation 4 is used to calculate [II-20]free (2.96 mM) using the known value of 
[II-5a • II-21]. 
Krel = ([II-5a• II-28][ II-20]free) / ([II-5a• II-20][ II-28]free)                     (1) 
[II-28]Total = 1.92 mM = [II-28]free + [II-5a• II-28]                      (2) 
[II-5a]Total = 1.44 mM = [II-5a• II-28] + [II-5a• II-20]                    (3) 
[II-20]Total = 3.48 mM = [II-20]free + [II-5a • II-20]                     (4) 
Substitution of the values of [II-5a• II-28], [II-28]free, [II-5a• II-20], and [II-20]free into 
equation 1 gave Krel = 5.25. These determinations were done in triplicate from 
independently prepared stock solutions and the average values were used in the 
calculations of Ka and the error analysis shown below. 
In preparing the solutions for the above determinations we used a small excess of II-28 
(to ensure there is no free II-5a) and a large excess of II-20; under those conditions the 
errors in [II-21]free, [II-28]free are small and both [II-28] and [II-5a• II-28] are kept in a 














Figure II-S36. 1H NMR spectrum (400 MHz, 20 mM sodium phosphate buffer, pD = 7.4) 
recorded for a solution of II-5a (1.44 mM), II-20 (3.48 mM), II-28 (1.92 mM) and 






Figure II-S37. 1H NMR spectra (400 MHz, 20 mM sodium phosphate buffer, pD = 7.4) 







Figure II-S38. Plot of the chemical shift of II-20 as a function of II-6 concentration. The 
solid line represents the best non-linear fitting of the data to a 1:1 binding model (Ka = 

















 Figure II-S39. 1H NMR spectra (400 MHz, 20 mM sodium phosphate buffer, pD = 7.4) 








 Figure II-S40. Plot of the chemical shift of II-11 as a function of II-6 concentration. 
The solid line represents the best non-linear fitting of the data to a 1:1 binding model (Ka 





















Figure II-S41. (A) Fluorescence spectra from the titration of dye II-7 (0.42 µM) with II-
5b (0 – 10 µM) in 5 mM NaH2PO4 buffer (pH 7.4), excited at 520 nm and emission at 
550 nm; (B) plot of the ΔA550 as a function of II-5b concentration. The solid line 










Figure II-S42. (A) UV/Vis spectra from the titration of dye II-7 (4.14 µM) with II-5b (0 
– 15 µM) in 7.24 mM NaH2PO4 buffer (pH 7.4); (B) plot of the ΔA550 as a function of II-
5b concentration. The solid line represents the best non-linear fit of the data to a 1:1 









Figure II-S43. (A) UV/Vis spectra from the titration of dye II-7 (3.74 µM) with II-5b (0 
– 19 µM) in 9.52 mM NaH2PO4 buffer (pH 7.4); (B) plot of the ΔA550 as a function of II-
5b concentration. The solid line represents the best non-linear fit of the data to a 1:1 









Figure II-S44. (A) UV/Vis spectra from the titration of dye 7 (3.01 µM) with II-5b (0 – 
25 µM) in 11.83 mM NaH2PO4 buffer (pH 7.4); (B) plot of the ΔA550 as a function of II-
5b concentration. The solid line represents the best non-linear fit of the data to a 1:1 









Figure II-S45. (A) UV/Vis spectra from the titration of dye II-7 (4.15 µM) with II-5b (0 
– 25 µM) in 18.81 mM NaH2PO4 buffer (pH 7.4); (B) plot of the ΔA550 as a function of 
II-5b concentration. The solid line represents the best non-linear fit of the data to a 1:1 









Figure II-S46. (A) UV/Vis spectra from the titration of dye II-7 (3.28 µM) with II-5b (0 
– 35 µM) in 24.52 mM NaH2PO4 buffer (pH 7.4); (B) plot of the ΔA550 as a function of 
II-5b concentration. The solid line represents the best non-linear fit of the data to a 1:1 









 Figure II-S47. (A) UV/Vis spectra from the titration of dye II-7 (4.16 µM) with II-5b (0 
– 52 µM) in 31.27 mM NaH2PO4 buffer (pH 7.4); (B) plot of the ΔA550 as a function of 
II-5b concentration. The solid line represents the best non-linear fit of the data to a 1:1 









Figure II-S48. (A) UV/Vis spectra from the titration of dye II-7 (8.58 µM) with II-5b (0 
– 65 µM) in 40.44 mM NaH2PO4 buffer (pH 7.4); (B) plot of the ΔA550 as a function of 
II-5b concentration. The solid line represents the best non-linear fit of the data to a 1:1 








 Figure II-S49. (A) UV/Vis spectra from the titration of dye II-7 (8.52 µM) with II-5b (0 
– 82 µM) in 57.16 mM NaH2PO4 buffer (pH 7.4); (B) plot of the ΔA550 as a function of 
II-5b concentration. The solid line represents the best non-linear fit of the data to a 1:1 









 Figure II-S50. (A) UV/Vis spectra from the titration of dye II-7 (7.45 µM) with II-5b (0 
– 80 µM) in 73.8 mM NaH2PO4 buffer (pH 7.4); (B) plot of the ΔA550 as a function of II-
5b concentration. The solid line represents the best non-linear fit of the data to a 1:1 









Figure II-S51. (A) UV/Vis spectra from the titration of dye II-7 (9.88 µM) with II-5b (0 
– 64 µM) in 91 mM NaH2PO4 buffer (pH 7.4); (B) plot of the ΔA550 as a function of II-
5b concentration. The solid line represents the best non-linear fit of the data to a 1:1 






Figure II-S52. 1H NMR spectra (400 MHz, 20 mM sodium phosphate buffer, pD = 7.4) 








 Figure II-S53. 1H NMR spectra (400 MHz, 20 mM sodium phosphate buffer, pD = 7.4) 







Figure II-S54. 1H NMR spectra (400 MHz, 20 mM sodium phosphate buffer, pD = 7.4) 






III. Chapter 3. Why Aldehydes Usually Do Not Participate in 
CB[n] Forming Reactions. 
3.1 Introduction.  
          In 1981 Mock and co-workers disclosed that the condensation reaction of 
glycoluril (III-1H) with formaldehyde under strongly acidic conditions delivers 
cucurbit[6]uril (CB[6]) in high yield (Scheme III-1).13 In a series of elegant papers 
throughout the 1980’s, Mock established that CB[6] is a truly remarkable host with the 
ability to bind to alkaneammonium ions with high affinity and selectivity,44,45,74 to act as a 
bead in a pH switchable molecular shuttle,32 and even to accelerate the click reaction 
between certain acetylenes and azides.35,43 Around the turn of the millenium, the groups 
of Kim and Day reported that the condensation of glycoluril (1 equiv. generally > 1 M) 
with formaldehyde (2 equiv.) under milder conditions (e.g. conc. HCl, 100 ˚C) results in 
the formation of a homologous series of cucurbit[n]uril (CB[n]; n = 5, 6, 7, 8, 10) 
hosts.15,18,19 In the intervening years, the supramolecular chemistry of the larger CB[n] 
homologues (CB[7] and CB[8]) have been shown to be particularly exciting with 
applications ranging from molecular machines, chemical sensors, solid phases for 
sequestration and chromatography, and drug delivery vehicles. 37,41,42,50-70,103 
 




















































 As a result of these exciting recognition properties, a number of groups have been 
interested in the synthesis of CB[n] derivatives with new structures and tailor-made 
properties (e.g. enhanced solubility).  For this purpose, a number of synthetic strategies 
have been investigated (Scheme III-2).23,104  For example, the condensation reaction 
between a few substituted glycolurils (III-1R) and formaldehyde was shown to give 
R10CB[5] and R12CB[6] compounds (Scheme III-2a). Cy5CB[5] and Cy6CB[6] have 
enhanced solubility in organic solvents and can be used in the formation of ion-selective 
electrodes.104 Unfortunately, the self-condensation of a single glycoluril derivative (e.g. 
III-1Me) does not yield any substituted CB[7] or CB[8] presumably due to steric 
interactions between substituents that increase as the size of the ring increases.90 To 
address this concern a number of researchers have performed the condensation between 
two different glycolurils and have been able to isolate partially substituted CB[n] 
(Scheme III-2b).88,90,105,106 For example, the condensation of 1H and 1Ph resulted in the 
formation of Ph2CB[6].105 Other research groups have developed building block 
strategies31,73 based on condensation between glycoluril monomers and glycoluril 
oligomers.88 For example, the group of Tao demonstrated the condensation between 
glycoluril dimer III-2C and bis(cyclic ether) III-1MeBCE yields Me4CB[6] (Scheme 2c).88 
Perhaps the most useful method for the synthesis of CB[n] derivatives involves the direct 
functionalization of preformed CB[n] (n = 5, 6).24  For example, Kim’s group has 
described the perhydroxylation of CB[n] (n = 5, 6) to yield (HO)2nCB[n] (n = 5, 6)107 
which is amenable to further functionalization reactions (Scheme III-2d) which allows 






Scheme III-2.  Synthesis of substituted CB[6] compounds. 
 
          All of the methods described above involve the use of glycoluril derivatives or the 
functionalization of the convex face of the glycoluril ring system.  Is it possible to expand 
the scope of the CB[n] forming reaction beyond formaldehyde (Scheme III-2d)?  
Although this question has been posed and attempted experimentally by several 
researchers, the reasons behind the failure of such synthetic routes have remained unclear 
to date.103 In this paper, we address this question and delineate two of the reasons why 
aldehydes do not generally participate in CB[n] forming reactions. 
 
3.2 Results and Discussion.   
          This results and discussion section is organized as follows.  First, we present a 
summary of a portion of the mechanism of CB[n] formation proceeding via oligomers 
III-2 – III-6 which is relevant to the use of aldehydes in CB[n] forming reactions.  Next, 
we present the unsuccessful attempts to react glycolurils with mono-aldehydes followed 
by the successful synthesis of several S-shaped glycoluril dimers from glycolurils and o-
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phthalaldehyde.  We use the results of these experiments along with product 
resubmission experiments to explain why aldehydes do not generally participate in CB[n] 
forming reactions. 
 
3.2.1 Mechanism of CB[n] Formation.   
          The Isaacs group has been heavily involved in the elucidation of the mechanism of 
CB[n] formation.73,81,108,109 This section presents an overview of portions of the 
mechanism of CB[n] formation (Scheme III-3) that are relevant to our discussion of the 
use of aldehydes in CB[n] forming reactions.  Initially, glycoluril III-1H undergoes 
condensation with formaldehyde to yield a mixture of C-shaped and S-shaped glycoluril 
dimers (III-2C and III-2S).  Diastereomers III-2C and III-2S differ in the relative 
orientation of the pairs of methine H-atoms on the convex face of each equivalent of 
glycoluril.  Previously, we studied the equilibrium between the C-shaped and S-shaped 
forms using end-capped derivatives of III-1COOEt and established a large (> 95:5) 
thermodynamic preference for the C-shaped form.108 Subsequently, the III-2C may grow 
to yield trimer (III-3), tetramer (III-4), pentamer (III-5), hexamer (III-6), and higher 
oligomers by the stepwise addition of III-1H. When the oligomer is long enough (e.g. III-
5 or III-6) addition of 1 equivalent of formaldehyde yields nor-seco-CB[n] which then 
goes on to yield CB[n] by addition of a final equivalent of formaldehyde.  The Isaacs 
group has previously isolated ns-CB[6] and demonstrated its conversion to CB[6] by 
product resubmission experiments.22 It is also possible for oligomers (e.g. III-3 or III-5) 





cavity (bis-ns-CB[10]) or even chiral ((±)-ns-CB[6]) structures.20,21 Please note that in the 
depicted mechanism (Scheme III-3) oligomers III-2 – III-6 are connected by equilibrium 
arrows which reflect the reversibility of these steps.  At this time no quantitative 
information is available regarding the equilibrium constants for any of these steps.  In 
contrast, Day has demonstrated by product resubmission experiments that the final 
conversion to CB[6] is an irreversible step and is indicted as such in Scheme 3.16 Another 
fact worth noting is that CB[n] formation is a condensation reaction and that one 
molecule of H2O is produced (highlighted in aqua) for each molecule of CH2O that is 
consumed.  Two factors that are critical in the successful formation of CB[6] from 1H and 
CH2O are: 1) that the equilibrium between III-1H + CH2O and III-2S / III-2C + H2O 
favors the dimers, and 2) that the equilibrium between S-shaped (e.g. III-2S) and C-
shaped (e.g. III-2C) diastereomers greatly favors the C-shaped forms. 
 
Scheme III-3.  Portion of the mechanism of CB[n] formation. 
 
3.2.2 Reactions Between Capped Glycoluril 7 and Some Aldehydes Do Not Yield 






































































































































          As described above it is critical that the equilibrium between III-1H + 
formaldehyde and III-2C / III-2S + H2O favors products for a successful CB[n] forming 
reaction.  We wondered whether this fundamental step of the mechanism of CB[n] 
formation would still favor products when aldehydes are used instead of formaldehyde.  
To address this question we decided to use capped glycoluril derivative III-7 in place of 
III-1H to limit the complexity of the reaction to the formation of dimers.110-112 Scheme III-
4 shows the theoretical reaction between III-7 and an aldehyde to yield dimers 
comprising two equivalents of III-7 and two equivalents of aldehyde.  Similar to the 
condensation of III-1H and formaldehyde described above (Scheme III-3), there are two 
sets of diastereomers (C-shaped: III-9a – III-9c and S-shaped: III-9d – III-9e) that differ 
in the orientation of the H-atoms on the convex face of the glycoluril ring system.  In 
addition, the use of an aldehyde generates two new stereogenic centers each of which 
could conceivably adopt two possible configurations.  In total, five possible 
diastereomers could be formed (Scheme III-4). 
 
Scheme III-4.  Possible products from condensation of III-7 and an aldehyde. 
 
First, we investigated the reaction between III-7 (100 mM) and benzaldehyde 
(III-8Ph, 100 mM) in conc. DCl at 70 ˚C.  Analysis of the 1H NMR spectrum of the crude 


















































































resonances corresponding to the formation of III-9 were not observed.  Based on this 
result we surmised that benzaldehyde and III-7 are not sufficiently reactive (e.g. starting 
materials are favored under normal concentrations) and that eventually III-7 and III-8Ph 
undergo decomposition reactions instead.  To be certain that this observation was not due 
to the particular experimental conditions we conducted several additional sets of 
experiments.  In one set of experiments we varied the concentrations of III-7 and III-8Ph 
(1 mM – 1 M) and still did not observe any dimer formation by 1H NMR.  In a second set 
of experiments we varied the temperature (70 ˚C, 50 ˚C, and room temperature) and 
followed the reaction by 1H NMR.  Once again we could not detect the formation of 
dimers.  Given that the reaction between III-7 and an aldehyde is a condensation reaction 
that leads to the formation of H2O as byproduct we decided to conduct the reaction under 
anhydrous (CF3CO2H) rather than aqueous (conc. HCl) conditions.  We hoped that the 
use of CF3CO2H as solvent would favor the formation of dimer as a consequence of Le 
Chatelier’s principle.  Unfortunately, similar to the reactions in HCl as solvent we did not 
observe the formation of any dimeric products.  In many of the reactions between III-7 
and III-8Ph we observed the formation of hydantoin side product III-SP1 in low yield 
(Scheme III-5a).  This result is consistent with the known tendency of glycolurils to 
undergo transformation into hydantoins110,113 followed by condensation with III-8Ph.  
Similar attempted dimerization reactions were conducted between III-7 and acetaldehyde 
(III-8Me), pivaldehyde (III-8t-Bu), and acrolein (III-8CH=CH2).  In these cases 1H NMR 
showed the loss of the resonances due to the starting aldehyde, but no resonances that 






Scheme III-5.  Reactions between III-7 and a) benzaldehyde and b) butanal. 
 
          We also conducted the reaction between III-7 (1 M) and III-8Pr (1 M) in TFA at 50 
˚C (Scheme III-5b).  Once again, we did not observe the formation of dimer, but in this 
case we were able to isolate (±)-III-SP2 in 67% yield.114 Compound (±)-III-SP2 is an N-
acyl enamine that forms from 1 equivalent of III-7 and 2 equivalents of III-8Pr. We 
believe that (±)-III-SP2 probably forms results from intramolecular enamine-iminium ion 
condensation of intermediate III-I.  The isolation of (±)-III-SP2 provides strong 
evidence that aldehydes do react with glycoluril NH groups under acidic conditions but 
that other factors may divert the reaction away from the formation of methylene bridged 
glycoluril dimers that are required for CB[n] formation. 
 
3.2.3 Reaction Between ns-CB[6] and Phthaldehyde.   
          Our lack of success in the reactions described in the previous section was 
somewhat surprising to us given that we previously reported that the reaction between ns-





































Compound III-10 is somewhat unusual in that it contains an N-C-O-C-N bridge rather 
than the standard N-C-N connection typical of CB[n] reactions.  Despite this idiosyncrasy 
it was clear that III-11 – probably facilitated by the entropic advantage provided by using 
a dialdehyde – was sufficiently reactive to participate in a CB[n] forming reaction.  
Accordingly, we wondered whether phthaldehyde III-11 would be reactive toward 
glycolurils and glycoluril oligomers and provide a new route toward the formation of 
CB[n] derivatives. 
 
Scheme III-6.  Synthesis of III-10. 
 
3.2.4 Reaction Between Glycolurils and Phthaldehyde III-11.   
          Given our interest in the development of building block strategies28,73 for the 
construction of CB[n] derivatives and analogues we wondered whether III-11 would 
participate in such reactions.  First, we decided to conduct the reaction between glycoluril 
dimer III-2C (3 equiv.) and III-11 (3 equiv.) in the hopes of creating a CB[6] derivative.  
This experiment was conducted in CF3CO2H rather than HCl because III-2C is nicely 
soluble in CF3CO2H.  Contrary to expectation, we observed the formation of tetramer III-
12S (Scheme III-7a) whose structure was established by spectroscopic methods and also 













































1H NMR which may correspond to diastereomers III-12Ca and III-12Cb. The formation 
of III-12S was very interesting to us for a number of reasons.  First, phthaldehyde III-11 
displayed a more normal reactivity in which the o-xylylene ring acts as bridge between 
the 1,5-positions of the newly formed 8-membered ring.  Second, even though the 
condensation of two molecules of III-2C and one molecule of III-11 could, in theory, 
yield three diastereomers (III-12S, III-12Ca, and III-12Cb) we observe the dominant 
formation of III-12S.  Next, we examined the reaction between phthaldehyde III-11 and 
glycoluril III-1H or capped glycolurils III-7, III-13, and III-14.  In all cases, we observed 
the dominant formation of a single product (III-15S – III-18S) with an S-shaped 
geometry (Scheme III-7b – 7e).  We were fortunate to obtain single crystals of III-12S, 
III-16S, and III-17S and solve their structures (Figure III-1).  Figure 1a shows the x-ray 
crystal structure of III-12S which illustrates the overall S-shape of the oligomer due to 
the relative orientation of the methine C-H groups on the convex face of two equivalents 
of building block III-2C within III-12S.  Figure 1b shows the x-ray crystal structure of 
III-16S which adopts a very similar geometry.  In this case solvating MeOH molecules 
within the crystal form O-H•••O=C H-bonds to the ureidyl carbonyls of III-16S.  
Compound III-17S also displays a similar overall geometry in the crystal (Figure III-1c), 
but in this case the bridging o-xylylene rings of two adjacent molecules of III-17S in the 






























































































































































Figure III-1.  Cross-eyed stereoviews of the x-ray crystal structures of: a) III-12S, b) 
III-16S, and c) III-17S rendered with CrystalMaker™.  Color code: C, grey; H, white; N, 
blue; O, red; H-bonds, red-yellow striped. 
The formation of the S-shaped diastereomers III-12S and III-15S – III-18S is of high 
relevance toward the use of III-11 or aldehydes in CB[n] forming reactions.  The 
formation of S-shaped subunits prevents the reactive NH tips of the oligomers from being 
close enough in space to undergo macrocyclization reactions.  For this reason the use of 
III-11 in CB[n] forming reactions is unlikely to be successful.  We surmise that the 
reaction between ns-CB[6] and III-11 is successful because ns-CB[6] is preorganized 
into the C-shape needed for macrocyclization before reaction with III-11. 
 
3.2.5 Why Do the S-shaped Diastereomers Predominate?   
          The results described above and supported further below by product resubmission 
experiments establish that the S-shaped diastereomers III-12S and III-15S – III-18S are 
more stable than the corresponding C-shaped diastereomers.  More importantly, why do 
the S-shaped forms predominate in this case?  An examination of the x-ray crystal 
structure of III-2C81 and the MMFF94s energy minimized structures of III-16S, III-
16Ca, and III-16Cb (Figure III-2) gives some insights.  The central 8-membered ring of 
III-2C exists in the crown-conformation (Figure III-2a).115-118 Introduction of the bridging 
o-xylylene ring in III-12 and III-15 – III-18 results in the formation of two new seven 
membered rings (7-MR).  It is well known that 7-MR prefer the chair conformation over 





conformation whereas the other adopts the boat form.  For III-16Cb both of these new 7-
MR adopt the chair conformation whereas for III-16Ca both adopt the boat 
conformation.  This analysis predicts that III-16Cb should be the most stable 
diastereomer followed by III-16S and finally III-16Ca which is contrary to the observed 
dominant formation of III-16S.  Accordingly, we calculated the relative heats of 
formation of III-16S, III-16Cb, and III-16Ca of the MMFF94s minimized conformers 
using the PM3 method and found that theory predicts that III-16S is 2.21 kcal mol-1 more 
stable than III-16Cb (chair-chair) and 11.29 kcal mol-1 more stable than III-16Ca (boat-
boat).  We believe that unfavorable H•••H non-bonded interactions (2.01Å)119 between H-
atoms on adjacent glycoluril rings (Figure III-2c) destabilize III-16Cb.  On the basis of 
this analysis, it becomes clear that the conformational preferences of the newly forming 
8-MR and 7-MR control the diastereomer (e.g. S-shaped or C-shaped) that is formed.  
For a CB[n] derivative forming reactions to proceed smoothly it is critical that the 







Figure III-2.  Stereoscopic representations of the x-ray crystal structure of a) III-2C and 
the MMFF94s minimized geometries of b) III-16S, c) III-16Cb, and d) III-16Ca.  Color 
code: C, grey; H, white; N, blue; O, red.  The quoted relative heats of formation (kcal 
mol-1) were obtained from PM3 calculations. 
 
3.2.6 Product Resubmission Experiments.   
          In combination, the synthetic and theoretical studies described above strongly 
suggested that the S-shaped diastereomers III-12S and III-15S – III-18S were 





system studies of the equilibrium between S-shaped and C-shaped methylene bridged 
glycoluril dimers we used product resubmission experiments to transform the S-shaped 
diastereomers into the C-shaped forms.108 We decided to attempt similar experiments 
with III-16S.  Accordingly, we monitored the composition of a solution of III-16S (12.5 
mM) in 5% DCl at room temperature and observed a decrease in the concentration of III-
16S over several days and somewhat surprisingly an increase in the concentration of 
glycoluril monomer III-7 (Figure III-3a). No 1H NMR resonances were detected that 
would indicate the formation of C-shaped diastereomers III-16Ca or III-16Cb which is 
in accord with the PM3 calculation described above.  The observation of the mixture of 
S-shaped dimer III-16S and glycoluril monomer III-7 suggested to us that the 
equilibrium constant for the conversion of III-7 and III-11 into III-16S and H2O might 
be small due to the decreased reactivity of III-11 relative to formaldehyde.  To further 
verify this hypothesis, we dissolved III-16S in 5% DCl at room temperature at different 
concentrations (50 mM, 12.5 mM, 3.8 mM, and 1 mM) and followed the decrease in the 
mole fraction of III-16S by 1H NMR spectroscopy (Figure III-3b).  We also followed the 
formation of III-16S from equimolar mixtures of glycoluril monomer III-7 and 
phthaldehyde III-11 under identical conditions (Figure III-3a).  Figure III-3 shows two 
important trends.  First, both the formation and fragmentation of III-16S plateau at 
comparable mole fractions of III-16S. Second, as the concentration increases from 1 mM 
to 50 mM we observe an increase in the mole fraction of III-16S at the plateau level.  
Both of these observations suggest that the conversion of III-7 and III-11 into III-16S 
and H2O is an equilibrium process with a modest equilibrium constant.  In sharp contrast 





starting materials over a range of conditions, the use of less reactive phthalaldehyde III-
11 results in only partial dimerization in the 1 – 50 mM concentration regime.  We infer 
that the lack of observed reactivity between III-7 and benzaldehyde probably reflects an 
even lower equilibrium constant that cannot be accessed over the concentration range 
employed (up to 1 M). 
 
Figure III-3.  Plots of mole fraction of III-16S versus time for the a) formation and b) 
fragmentation of III-16S.  Conditions: 5% DCl in D2O, room temperature.  The solid 
lines are intended merely as guides for the eye. 
 
3.2.7 Equilibrium and Reversibility of Formaldehyde Based Dimers.   
          The previous section demonstrated that the formation of glycoluril dimer III-16S 
from III-7 and phthaldehyde III-11 is a reversible process with the mole fraction of III-
16S experiencing large changes over the 1 – 100 mM range.  As further evidence of the 
relevance of this behavior to CB[n] forming reactions similar experiments were 
performed on the transformation of III-7 and formaldehyde into III-19C (Scheme III-8) 





than aldehydes we anticipated that we would need to resort to higher temperatures to 
entropically favor monomer III-7.  Figure III-4a shows a plot of mole fraction of III-19C 
versus time obtained during the formation of III-19C (5% DCl, 70 ˚C) at three different 
concentrations.  In all three cases we observe an initial increase in the mole fraction of 
III-19C followed by a maximum and finally a decrease.  At higher concentrations the 
mole fraction reaches a higher maximal value and decreases more slowly after this 
maximum is reached.  As a complementary experiment we dissolved III-19C in 5% DCl 
at 70 ˚C and followed the fragmentation of III-19C by 1H NMR as a function of time 
(Figure III-4b).  At higher concentrations of III-19C the mole fraction of III-19C 
decreases more slowly.  We interpret this behavior as being indicative of two competing 
processes: 1) equilibrium between III-7 and dimer III-19C, and 2) chemical 
decomposition of glycoluril monomer III-7. We performed identical experiments at 50 
˚C in 5% DCl (Figure III-4c and III-4d) and observe clearer plateau regions which 
indicates lower levels of side reactions (e.g. decomposition) relative to monomer-dimer 
equilibrium at this temperature. 
 







Figure III-4.  Plots of mole fraction of III-19C versus time for the a) formation, b) 
fragmentation of III-19C (5% DCl in D2O, 70 ˚C), c) formation, and d) fragmentation of 
III-19C (5% DCl in D2O, 50 ˚C).  The solid lines are intended merely as guides for the 
eye. 
 
3.3 Conclusions.   
          We have shown that glycolurils react with a dialdehyde (o-phthaldehyde) to deliver 
S-shaped glycoluril dimers III-15S – III-18S and tetramer III-12S.  We established that 
S-shaped compounds III-12S and III-15S – III-18S are thermodynamically preferred 
over the C-shaped diastereomers and trace this preference to the conformational biases of 
the newly formed benzo bicyclo[3.3.2]octane ring system.  The presence of S-shaped 





holding the reactive NH groups far apart in space.  Accordingly, the observation of the 
dominant formation of S-shaped dimers in the reaction between glycolurils and III-11 
provides one reason for the inability of o-phthalaldehyde and possibly other aldehydes to 
participate in CB[n] forming reactions.  The side products observed in the reaction 
between III-7 and aldehydes III-8Ph and III-8Pr illustrates two alternative reaction 
pathways (hydantoin formation and enamine-iminium ion cyclization) that become viable 
when less reactive aldehydes are used. 
We used product resubmission experiments to provide evidence for an 
equilibrium between dimer III-16S and monomer III-7 that responds to changes in 
concentration over the 1 – 50 mM range.  This indicates that the equilibrium constant for 
dimer formation with o-phthalaldehyde is modest and that high concentrations of starting 
materials are needed to drive the reaction toward completion.  In contrast to the results 
obtained with o-phthalaldehyde, we did not observe any reaction between benzaldehyde 
and glycoluril 7 under the range of concentrations (1 mM – 1 M) employed.  We interpret 
this result as meaning that the reactivity of aldehydes toward glycolurils is even lower 
(lower equilibrium constant) than that of o-phthalaldehyde III-11.  Given that 
concentrations of 50 mM are needed to drive the reaction with o-phthalaldehyde III-11 to 
completion perhaps it is not surprising that mono-aldehydes do not react with glycolurils 
at concentrations up to 1 M.  Accordingly, these results point toward poor reactivity (low 
equilibrium constant) as a second reason for the inability of aldehydes to participate in 






The delineation of two of the reasons why aldehydes do not generally participate in 
CB[n] forming reactions – the critical importance of the S- to C-shaped equilibrium and 
the magnitude of the equilibrium constant for chain growth – is important because it 
suggests methods to overcome these limitations in the future.  When it is possible to 
introduce functionality onto the bridging CH2-groups of CB[n] we expect that the range 
of applications (e.g. targeted drug delivery, affinity chromatography, and sensing arrays) 
to which CB[n] derivatives103 can be applied will expand.   
 
3.4 Experimental Section.   
          General experimental details have been reported previously.69,112 Starting materials 
were obtained from commercial suppliers and used without further purification.  
Compounds III-2C, III-7, III-13, and III-14 were prepared by the literature 
procedures.81,112 Compound III-SP1 has been reported in the literature previously.114  
 
Compound III-12S.  Compound III-2C (498 mg, 1.62 mmol) was dissolved in a mixture 
of TFA and water (19:1, v:v, 6 mL) and o-phthaldiadehyde (108 mg, 0.81 mmol) was 
added. The mixture was heated at 70 ˚C for 3 hours.  The solution was then poured into 
MeOH (150 mL). The precipitate was filtered to yield the crude product (580 mg).  The 
crude solid was stirred in a mixture of formic acid and water (1:2, v:v, 120 mL) 30 
minutes.  The filtrate was concentrated under reduced pressure and then poured into 
MeOH (200 mL).  After filtration and drying, the precipitate was further purified by 





(216 mg, 0.30 mmol, 37%). M.p. 350 ˚C (dec.).  IR (ATR, cm-1): 3450w, 1715s, 1445s, 
1318m, 1228s, 1185s. 1H NMR (400 MHz, DMSO-d6): 7.71 (s, 2H), 7.61 (s, 2H), 7.60-
7.55 (m, 2H), 7.45-7.40 (m, 2H), 6.46 (s, 2H), 5.56 (d, J = 14.6 Hz, 2H), 5.54 (d, J = 6.8 
Hz, 1H), 5.42 (d, J = 14.6 Hz, 2H), 5.41 (d, J = 8.6 Hz, 1H), 5.30 (d, J = 8.6 Hz, 1H), 
5.23 (d, J = 8.6 Hz, 1H), 5.13 (d, J = 8.6 Hz, 1H), 5.10 (d, J = 8.6 Hz, 1H). 4.79 (d, J = 
8.6 Hz, 1H), 4.16 (d, J = 14.6 Hz, 2H), 4.06 (d, J = 14.6 Hz, 2H). 13C NMR (100 MHz, 
TFA, external DMSO reference): δ 158.6, 158.5, 154.5, 153.8, 130.1, 129.6, 127.8, 72.5, 
72.3, 69.0, 68.5, 63.7, 61.7, 61.5, 61.3, 49.5, 49.1 (Only 17 of the 18 expected resonances 
were observed).  MS (ESI): m/z 715 ([M + H]+).  HR-MS (ESI+): m/z 715.2220, calc. for 
C28H27N16O8 715.2198.  X-ray crystal structure. 
Compound III-16S.  Compound III-7 (300 mg, 1.76 mmol) was dissolved in TFA (7 
mL) and o-phthaldialdehyde III-11 (120 mg, 0.89 mmol) was added. The mixture was 
stirred and heated at 60 ˚C for 3 hours. The solvent was removed under reduced pressure.  
The crude mixture was recrystallized from MeOH to yield III-16S as a white crystalline 
solid (300 mg, 0.68 mmol, 77%).  M.p. 322 ˚C (dec.).  TLC (CHCl3/MeOH 6:1) Rf 0.28.  
IR (ATR, cm-1): 3493w, 3003w, 2933w, 1692s, 1482s, 1405s, 1380s, 1203s, 1036s.  1H 
NMR (400 MHz, CDCl3): 7.50-7.45 (m, 2H), 7.40-7.35 (m, 2H), 6.59 (s, 2H), 5.34 (d, J 
= 7.9 Hz, 1H), 4.93 (d, J = 8.4 Hz, 1H), 4.85 (d, J = 7.9 Hz, 1H), 4.84 (d, J = 8.4 Hz, 1H), 
3.01 (s, 6H), 2.84 (s, 6H).  13C NMR (100 MHz, CDCl3): d 155.2, 155.2, 134.2, 130.0, 
129.2, 71.2, 71.1, 64.9, 64.3, 62.3, 30.2, 29.8.  MS (ESI): m/z 439 ([M + H]+). HR-MS 






3.5 Supporting Information 
Compound III-SP1.  A solution of III-7 (102 mg, 0.60 mmol) and III-8Ph (64 mg, 0.60 
mmol) in TFA (0.60 mL) was heated at 70 ˚C for 4 d. The solvent was removed by rotary 
evaporation. The crude solid was dissolved in CHCl3 (1 mL) and washed with water (2 
mL). The organic layer was evaporated with reduced pressure and the solid was 
recrystallized from ethanol (1 mL) to yield III-SP1 as a white solid (12 mg, 10%).  The 
spectroscopic data match that reported in the literature.  
Compound III- (±)-SP2.  To a solution of III-7 (102 mg, 0.60 mmol) in TFA (0.6 mL), 
III-8Pr (43 mg, 0.60 mmol) was added.  The solution was heated at 50 ˚C for 24 h. The 
solvent was removed by rotary evaporation.  The crude solid was washed with CHCl3 (3 
mL). After filtration, the filtrate was concentrated under reduced pressure and then 
further purified by column chromatography (SiO2, 20:1, CH2Cl2/CH3OH, v:v) to yield a 
waxy yellow solid (56 mg, 67%). TLC (CH2Cl2/CH3OH, 20:1, v:v) Rf = 0.12.  IR (KBr): 
3400m, 2961s, 2874m, 1708s, 1465s, 1411s, 1351m, 1233s, 1172m, 1107m, 1034m, 
820m, 790m, 755m. 1H NMR (400 MHz, CDCl3): 6.42 (s, 1H), 5.18 (d, J = 7.4, 1H), 
5.03 (d, J = 7.4, 1H), 4.20 (d, J = 8.0, 1H), 3.01 (s, 3H), 2.98 (s, 3H), 2.15-2.00 (m, 2H), 
1.75-1.70 (m, 1H), 1.50-1.35 (m, 3H), 1.05 (t, J = 7.4, 3H), 0.97 (t, J = 7.0, 3H). 13C 
NMR (150 MHz, CDCl3): 158.5, 156.2, 122.7, 116.5, 71.8, 60.8, 51.9, 35.2, 30.1, 29.9, 
24.5, 19.0, 13.7, 12.1.  MS (ESI): m/z 279 ([M + H]+). HR-MS (ESI): [M + H]+ = 
279.1829, calc. for C14H23N4O2 279.1821. 
Compound III-15S.  Compound III-1H (450 mg, 3.17 mmol) was dissolved in TFA (5 





stirred and heated at 70 ˚C for 24 hours.  The solvent was removed under reduced 
pressure.  The crude solid was washed with MeOH (10 mL) and then centrifuged to 
obtain a brown solid.  The crude brown solid was further purified by recrystallization 
from water H2O twice to yield 5 as a yellow powder (136 mg, 0.35 mmol, 23%).  M.p. 
302 ˚C (dec.).  IR (ATR, cm-1): 3266w, 1699s, 1426m, 1346m, 1212m, 1094m.  1H NMR 
(400 MHz, DMSO-d6): 7.96 (s, 2H), 7.63 (s, 2H), 7.55-7.45 (m, 2H), 7.45-7.35 (m, 2H), 
6.29 (s, 2H), 5.30-5.20 (m, 2H), 5.18 (d, J = 8.4 Hz, 1H), 4.77 (d, J = 8.4 Hz, 1H). 13C 
NMR (100 MHz, DMSO-d6): d 156.4, 156.3, 135.1, 129.5, 129.0, 67.9, 65.6, 63.5, 59.4, 
59.3.  MS (ESI): m/z 383 ([M + H]+).  HR-MS (ESI+): m/z 383.1226, calc. for 
C16H15N8O4 383.1216.  
Compound III-17S. A mixture of III-13 (300 mg, 1.6 mmol) and o-phthaldialdehyde 
III-11 (110 mg, 0.8 mmol) in TFA (7 mL) was refluxed under nitrogen for 4 hours. The 
solvent was removed under reduced pressure and the crude product was recrystallized 
from methanol to yield III-17S (360 mg, 94%).  M.p. > 300 ˚C (dec.).  TLC 
(CHCl3/MeOH 7:1) Rf 0.27.  IR (KBr, cm-1): 2947w, 1709s, 1466s, 1444s, 1385m, 
1358m, 1246s, 1163w, 1101m.  1H NMR (300 MHz, CDCl3): 7.56-7.52 (m, 2H), 7.43-
7.39 (m, 2H), 6.50 (s, 2H), 5.18 (d, J = 7.76, 2H), 5.14 (s, 2H), 4.82 (d, J = 7.76, 2H), 
4.19-4.13 (m, 2H), 3.95-3.90 (m, 2H), 3.17-3.07 (m, 2H), 3.02-2.92 (m, 2H), 1.64-1.48 
(m, 2H), 1.31-1.19 (m, 2H).  13C NMR (75 MHz, DMSO-d6): 154.8, 154.2, 134.9, 129.4, 
129.3, 67.3, 65.2, 64.3, 63.5, 63.3, 59.7, 62.5, 38.4, 38.3, 23.2, 22.9, 22.8.  HRMS (ESI+) 
m/z calcd for [C22H23N8O4 + H]+ 463.1842 found 463.1841. 
Compound III-18S. A mixture of o-xylyleneglycoluril III-14 (300 mg, 1.2 mmol) and o-





for 4 h. After cooling down white solid precipitated from the solution and was collected 
by filtration, washed with water and dried under vacuum (19 mg, 5%).  The content of 
III-18S in the crude reaction mixture is >50% based on NMR integration.  M.p. > 300 ˚C 
(dec.). IR (KBr, cm-1): 2970w, 1728s, 1685s, 1498s, 1344w, 1321w, 1250m, 1176w, 
1097w.  1H NMR (300 MHz, DMSO-d6 ): 7.51-7.49 (m, 2 H), 7.37-7.32 (m, 4H), 7.30-
7.27 (m, 2H), 7.15-7.08 (m, 4H), 6.30 (s, 2H), 5.68 (d, J = 7.9, 1H), 5.47 (d, J = 7.6, 1H), 
4.78 (d, J = 7.9, 1H), 4.70 (d, J = 15.5, 2H), 4.63 (d, J = 15.5, 2H), 4.46 (d, 1H), 4.43 (m, 
4H).  13C NMR (75 MHz, DMSO-d6): 153.7, 153.6, 137.5, 137.3, 134.6, 129.6, 129.4, 
129.2, 129.1, 127.7, 127.5, 68.4, 68.1, 64.7, 63.8, 61.1, 45.2, 45.1.  HRMS (ESI+) m/z 








































Figure III-S6. 13C NMR spectrum (100 MHz, TFA, DMSO as external reference) 
















Figure III-S9.  
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ІV. Chapter 4: Summary and Future Work 
 
4.1 Summary. 
          In this thesis, we discussed the work to develop new CB[n] type hosts and the 
mechanism investigation related to this study.   
          Supramolecular chemistry has been a very important research area.  Molecular 
containers, especially cyclodextrin, have wide applications, both academically and in 
industry.  Cucurbit[n]uril, a new generation of molecular container, is well-known for its 
tight and selective binding property.  Yet, its poor solubility in water and difficulty to be 
functionalized are two significant issues which stop it from wider applications.   
          In order to circumvent these issues, a new type of acyclic CB[n] congeners has 
been developed (e.g. II-5a).  It has a moderate solubility in water.  It retains most of the 
recognition property of CB[n].  Due to its acyclic structure, it has fast association and 
dissociation kinetics.  The importance of this new types of host is not limited to their own 
interesting property.  This work also proves that it is possible to make new acyclic 
congener with interesting functional groups and very good recognition property.  The 
synthesis of a new CB[n]-type receptors with high water solubility is a future research 
goal.   
          We also looked into the condensation reactions of glycoluril and aldehydes, which 
might lead to functionalized CB[n].  But we and other researchers as well can not make 





why aldehydes usually do not participate in CB[n] forming reactions.  The reasons 
include 1) the formation of S-shape intermediate; 2) a reversible reaction with the 
equilibrium prefers to the reactant side; and 3) the formation of side products. 
          We believe our research expands the scope of CB[n] research area.  By making 
new molecular container and studying the mechanism of CB[n] forming reactions, we are 
able to achieve more applications and develop more novel molecular containers. 
 
4.2 Future Work. 
           As mentioned above, one of the issues for CB[n] application is its poor solubility 
in water.  If we can prepare CB[n] type receptors that are highly soluble in water, 
applications, especially medicinal applications, will be possible.  As shown in Scheme 
IV-1, this water soluble molecular container would be able to encapsulate hydrophobic 
drugs, and if the complex is water soluble, the drugs will be solubilized.  This strategy is 
very important in drug delivery area.  We believe it will be a very useful technology if we 
can make this water soluble host.  Its solubility might be not limited to hydrophobic drugs.  
Other compounds with poor aqueous solubility, such as nanotubes and polymers, are also 
candidates to be solubilized by such a water soluble CB[n]-type molecular container.  
 
          Another possibility is to introduce fluorescence groups into the structure.  
Biological sensing is a research area that has attracts wide attention.  Biological sensing 





most widely probes for biological sensing purposes.  If we can attach a fluorescence 
active group to a CB[n] type receptor, we will be able to monitor the locations of the 
guest molecules (Scheme IV-2).  There are a number of biological compounds that are 
able to form tight complex with CB[n], such as ammonium salts and some neutral 
compounds.  This technology may be very useful to easily track the exact locations of the 
compounds in the cell or animal body and visualize their distribution.  This technology 
utilizes non-covalent interactions, instead of forming covalent bonds, which means it 




Scheme IV-1. Water soluble CB[n] molecular container and its capability to solubilize 
hydrophobic drugs. 
 




CB[n] type receptor that
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